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ABSTRACT 
 
The regulation of linear growth is a complex and ‘intriguing’ process that has the 
growth plate cartilage as its final target. Growth plate is a specialized cartilage localized 
in the end of the long bones between the epiphyseal and metaphyseal bone. It consists 
of 3 layers (resting, proliferative and hypertrophic zones) with distinct cellular 
morphology and function, where the continuous process of endochondral ossification 
takes place. This process is tightly regulated and relies on the interaction between 
systemic and local action of several hormones and growth factors.  Although height is a 
true multigenetic trait and much has been discovered on the control of skeletal growth; 
there is still a long way to go to understand the intrinsic control of growth plate 
chondrogenesis that regulates postnatal bone growth and determines individual height.  
In order to explore the molecular mechanisms implicated in the spatial and temporal 
control of growth plate, we first used microdissection of postnatal rat growth plate 
combined with microarray and real-time PCR analyses. Bioinformatic analysis of 
global gene expression implicated novel biological functions, molecular pathways, 
transcription factors and potential markers for spatially-associated chondrocyte 
differentiation and temporally-associated growth plate senescence (Paper I).  
We next explored some of these molecular pathways implicated in the control of 
postnatal chondrogenesis. The Wnt/β-catenin signaling was one of the most strongly 
implicated pathways in the developmental program of growth plate senescence 
revealed in our microarray analysis. We found that six Wnts were expressed in growth 
plate chondrocytes, of which Wnts-2b, -4 and -10b act through the canonical β-catenin 
pathway and Wnts -5a, -5b and -11 acts through the non-canonical Calcium pathway. 
We observed that all the expressed Wnts exhibited a similar pattern of expression in the 
growth plate, showing low expression in resting zone, increasing expression as the 
chondrocytes differentiated into the proliferative zone, and then decreasing expression 
as the chondrocytes underwent hypertrophic differentiation. In addition, all identified 
Wnts persisted at similar levels with age. Altogether, our findings suggest that Wnts 
modulate growth plate senescence and chondrocyte hypertrophy through the canonical 
β-catenin and non-canonical calcium pathways (Paper II). We then, characterized the 
expression profile of a growth-regulated network of imprinted genes implicated in 
embryonic growth of soft tissues. We found that the expression pattern of the network 
is modified in growth plate cartilage compared both to soft tissues and to bone. In 
particular, developmental changes in the expression of growth-promoting genes (Mest, 
Dlk1, Gtl2), and growth-inhibitory genes (Cdnk1c and Grb10) may contribute to the 
decline in longitudinal bone growth that occurs with age (Paper III). In addition, by 
using distinct growth inhibiting conditions, we found functional and structural delay in 
growth plate senescence markers that indicate that growth plate senescence is not 
simply a function of time ‘per se’ but rather of growth, and that delayed senescence 
may be a general consequence of growth inhibition (Paper IV).  
We also identified unique microRNAs (miRNAs) that are preferentially expressed and 
age-regulated in growth plate chondrocytes. The role of these miRNAs in growth plate 
chondrogenesis were tested using in vitro system for culture and transfection of murine 
resting zone chondrocytes, which enabled us to study the role of miRNAs in primary 
chondrocytes phenotype, simulating in vivo conditions more closely. These findings 
suggest that miRNAs contribute to the developmentally regulated decline in 
longitudinal bone growth through regulation of chondrocyte proliferation and 
apoptosis. Altogether, our findings contribute to understand the molecular regulation of 
growth plate chondrocytes and its implications to postnatal linear growth (Paper V). 
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1 INTRODUCTION 
 
1.1 Longitudinal Bone Growth 
Growth is one of the most fundamental tasks of childhood development and growth 
assessment is an important screening tool in the pediatric health evaluation. Although 
tall stature is also a concern, especially among teenage girls, short stature is a more 
common cause of concern and one of the main causes of referral to the pediatric 
endocrinologist. Attaining the potential height for every child may be accompanied by 
parental expectation and anxiety, and lead to emotional issues in the children and 
adolescents as well. However, “physiological” factors need to be considered when 
evaluating a child’s growth, such as: inherited growth potential (parental height), 
“physiological age” (pubertal status and bone age), and “normal” variations in 
nutritional status.  
Human height is a quantitative trait with a clear pattern of family resemblance, 
consistent with a polygenic model of inheritance (Galton 1886; Visscher 2008). 
Recently, three genome-wide association and genetic linkage studies with a combined 
sample size of more than 60,000 individuals have tried to explain how much adult 
height is due to the polygenic model, searching for loci (presumable genes) that might 
contribute to the variation in adult height and at what extent. However, the 54 detected 
loci can only explain a small proportion (3-5%) of height variation among the 
population, with each locus having a small effect size of 0.3-0.6 cm (Gudbjartsson, 
Walters et al. 2008; Lettre, Jackson et al. 2008; Weedon, Lango et al. 2008).  The 
results of these studies suggest that height is a true multigenetic trait and that future 
studies with larger cohorts will detect many more genes with even smaller effect size. It 
is noteworthy that some of these studies found expected as well as unexpected genes, 
and implicates the role of micro-RNAs (miRNAs), such as let7 family, whose target 
genes (e.g. IGF1, IGF1R and COL1A2) are known as important regulators of human 
stature (Lettre, Jackson et al. 2008). However, there is still a long way to go by using 
this strategy and much more knowledge is required to understand the role of these 
genes and mechanisms of interaction between them in order to determine individual 
height. Since there are so many genes involved and very small size effects for each one 
of them, it seems unlikely that this approach will reach practical clinical application. 
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The regulation of linear growth is a complex and ‘intriguing’ process that has the 
growth plate cartilage as its final target, and relies on the interaction between systemic 
and local action of several hormones and growth factors. Throughout life, longitudinal 
growth constitutes a self-limited and decelerated process. Human growth velocity can 
be as high as 100cm/year or more in fetal life, 50cm/y at birth, remains around 5cm/y 
during late childhood, and stops just after the pubertal growth spurt (Karlberg 1987). 
Any disturbance in growth velocity may be an early indication of a great variety of 
hormonal and non-hormonal systemic diseases, which might compromise the 
individual’s final height (Simm and Werther 2005).  
While the influence of hormonal status has been better established, the local signaling 
pathways that regulate linear bone growth is not fully understood, although substantial 
progress in this field has been made (Kronenberg 2003).   Skeletal development and 
systemic hormonal regulation of growth will be briefly commented on. Then, the 
molecular mechanisms intrinsic to the growth plate that regulate proliferation and 
differentiation of chondrocytes within distinct zones and throughout age, as well as 
their repercussion on postnatal bone growth will be described in more detail.  
 
1.2 Skeletal Development 
The vertebrate skeleton is built from condensations of mesenchymal cells (MSC) that 
adhere through the expression of adhesion molecules and, under a selective regulation 
of genes, differentiate into either two processes: intramembranous or endochondral 
ossification (Hall and Miyake 2000; Kronenberg 2003). Intramembranous ossification 
is mainly responsible for the formation of the flat bones of the skull and medial 
clavicles; and result from direct differentiation of MSC into bone cells (osteoblasts), 
which lay down a matrix rich in type I collagen. Transcription factor such as RUNX2, 
previously named Cbfa1, is a key regulator of osteoblast differentiation (Ducy, Zhang 
et al. 1997; Komori, Yagi et al. 1997), as well as the Wnt-β/Catenin signaling pathway 
has been shown to be essential to direct MSC into osteogenic program (Day, Guo et al. 
2005). However, most of the skeleton, including the limbs, results from the process of 
endochondral ossification. 
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1.2.1 Endochondral Ossification (Limb Formation) 
Endochondral ossification constitutes a complex process where MSC become 
chondrocytes (cartilaginous cells), which are used as a template to form bone. During 
this process, chondrocytes secrete a matrix rich in type II collagen (Kosher, Kulyk et al. 
1986) and proteoglycan aggrecan, and express a selective set of genes and transcription 
factors that direct the formation of bone. Parallel to this process, cells at the border of 
mesenchymal condensations form perichondrial cells, which will form the 
perichondrium that surround cartilage of the developing bone (Kronenberg 2003).  
Endochondral Ossification (limb formation) 
 
Fig. 1. Endochondral ossification illustrated into sequential steps:  A) Mesenchymal cells (MSC) 
form a condensation, and B) undergo differentiation into cartilage cells (chondrocytes) to form the 
cartilaginous anlagen of the bone. C) Chondrocytes in the center of the shaft stop proliferating, 
undergo hypertrophy and induce blood vessels invasion (primary ossification center) and formation 
of bone collar. D) Then, bone cells (osteoblasts) are formed and originate the primary ossification 
center (primary spongiosa). Meanwhile, growth consists of chondrocyte proliferation in one 
dimension, hypertrophy, and mineralization of the surrounding matrix. Secondary ossification 
centers also form as blood vessels enter near the tips of the bone. E) Finally, growth plate cartilage 
rest between epiphyseal and metaphyseal bones during postnatal life. In the outer part of 
epiphysis, chondrocytes cells become articular cartilage. Adapted from Gilber, S.F., 2000. 
Endochondral ossification spreads outward in both directions from the center of the 
bone (Fig. 1). At the same time that the cartilage mould further enlarges through 
continued proliferation of chondrocytes, actively dividing osteoblasts arise in regions of 
the cartilage called ossification centers. As the ossification front get close to the ends of 
the cartilage mould, the chondrocytes stop proliferating, undergo hypertrophy and are 
replaced by bone, pushing out the cartilaginous ends of the bone to form the epiphyseal 
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cartilage (Gilbert 2000). Together with continuous chondrocyte proliferation, 
hypertrophic chondrocytes becomes the principal engine of bone growth, direct 
mineralization of their surrounding matrix rich in type X collagen, attract blood vessels 
trough the production of vascular endothelial growth factor (VEGF) as well as other 
factors, and attract chondroclasts that digest the matrix that will be later replaced by 
bone. In addition, hypertrophic chondrocytes direct adjacent perichondrial cells to 
become osteoblasts, forming a bone collar. Finally, the terminal hypertrophic 
chondrocytes undergo apoptosis, and the invading osteoblasts that lay down a bone 
matrix using the calcified cartilage matrix as a scaffold. As consequence, new bone is 
created progressively at the bottom of the growth cartilage, which results in 
longitudinal bone growth.  
 
1.3 Postnatal Growth Plate 
1.3.1 Structural Organization & Function 
The growth plate is the final target organ for endochondral ossification, which allows 
the elongation of long bones during post-natal life until late adolescence, when growth 
stops and the growth plates fuse, determining the final height of the individual 
(Hunziker 1994).  
This specialized cartilage is located in the end of the long bones, between the 
epiphyseal and metaphyseal bone, and consists of three histological and functionally 
discrete layers that follow an elegant developmental program (Burdan, Szumilo et al. 
2009) (Fig. 2). Proximal to the epiphysis (toward the end of the bone), chondrocytes in 
the resting zone (RZ) are small, round, singly or distributed in pairs within a compact 
extracellular matrix (ECM), with a low proliferation rate. In vivo studies in rabbits 
show that after removal of proliferative and hypertrophic zones,  leaving only RZ in the 
growth plate bed, a complete growth plate structure is re-established within 1 week, 
suggesting that RZ chondrocytes act as ’stem-like’ cells that continuously renew the 
pool of proliferative chondrocytes (Abad, Meyers et al. 2002). Furthermore, 
implantation of growth plate by placing resting zone ectopically, alongside the 
proliferative columns, induced 90-degree shift in the orientation of nearby proliferative 
zone chondrocytes, suggesting that RZ chondrocytes may be partially responsible for 
  
5  
the spatial organization of the growth plate into distinct zones of proliferation and 
hypertrophy as well (Abad, Uyeda et al. 1999; Abad, Meyers et al. 2002). 
 
Fig. 2. Structural Organization of the Growth Plate: Placed between epiphyseal and metaphyseal 
bone of long bones, the growth plate is formed by distinct zones that represent histological and 
functional stages of chondrocyte differentiation: resting (stem-like), proliferative and hypertrophic 
zones. 
 
Next, in the proliferative zone (PZ), chondrocytes assume a flattened, discoid shape and 
form column-like structures, resembling “stacks of coins”, that are oriented along to the 
long axis of the bone, thus directing the lengthening of the bone primarily in one 
dimension. This layer has a high proliferation rate and produces a matrix (ECM) rich in 
type II and type IX collagens (Hunziker and Schenk 1989; Nilsson and Baron 2004).  
In the hypertrophic zone (HZ), chondrocytes undergo major changes in their 
phenotype, marked by physical and biochemical changes that occur in a spatial and 
temporal manner. Hypertrophic chondrocytes lose their capacity to divide, decrease 
their DNA synthesis, and have a 10-fold increase in their intracellular volume 
(Hunziker, Schenk et al. 1987).  Rather than a passive swelling, this is an active 
process, marked by an increase in organelles such as mitochondria and the endoplasmic 
reticulum (Hunziker 1994). Chondrocyte hypertrophy has an important role in the 
longitudinal growth of the skeleton. The increase in height of chondrocytes is 
responsible for up to 73% of long bone growth, with the remainder being due to matrix 
synthesis and chondrocyte proliferation (Wilsman, Farnum et al. 1996). At the end of 
the cell columns, terminally differentiated hypertrophic chondrocytes, prepare the 
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surrounding matrix as a “scaffold on which osteoclasts build”, and bone gradually 
replaces the newly formed cartilage (Stump 1925).  They produce a calcified matrix 
rich in type X collagen (Hunziker 1994), and expression of alkaline phosphatase has 
been related to the widening of the growth plate by increasing phosphate ions required 
for calcification of the ECM. Finally, chondrocytes undergo apoptosis, and ECM is 
degraded, followed by invasion of the vascular channels and bone-marrow stromal 
cells. Essentially, the growth plate is an avascular organ that relies on diffusion of both 
oxygen and nutrients for cell metabolism from vascular arcades localized on the 
metaphyseal side of the growth plate (Skawina, Litwin et al. 1994).  There, vascular 
channels are aligned along the longitudinal axis of the bone, and contain an ascending 
and descending capillary system (Aharinejad, Marks et al. 1995). However, 
endochondral ossification doesn’t occur without vascular invasion of growth plate 
(Provot and Schipani 2007). It is worth noting that the vascular endothelial growth 
factor A (VEGFA), expressed solely by the hypertrophic chondrocytes, is a key factor 
responsible for vascular invasion (Gerber, Vu et al. 1999; Carlevaro, Cermelli et al. 
2000; Colnot and Helms 2001). At the same time, hypertrophic chondrocytes undergo 
apoptosis and vascular invasion occurs; bone collar formation is induced in the 
surrounding perichondrium (Chung, Lanske et al. 1998). Then, osteoblasts replace the 
disappearing cartilage with trabecular bone, and bone marrow is formed (Skawina, 
Litwin et al. 1994; Solomon, Berube et al. 2008).   
As long as the growth plate is able to produce chondrocytes, the bone continues to 
grow. The progression from proliferating to terminal differentiation of hypertrophic 
cells is the key to the growth of those skeletal elements that are formed by 
endochondral ossification. Without chondrocyte proliferation and hypertrophy, 
endochondral bones cannot grow in length, and without hypertrophic cell death and the 
concomitant vascular invasion, the cartilage model cannot be replaced by bone. The 
study of molecular mechanisms that regulate chondrocytes proliferation and 
differentiation is an ongoing process, and there is still a lack of knowledge on how 
known and unknown mechanisms works together to regulate linear bone growth. 
1.3.2 Growth Plate Senescence 
Parallel to the observed decline in postnatal growth rate, growth plate undergoes 
structural and functional changes that appear to be due to intrinsic mechanisms, rather 
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than caused by changes in hormonal or any other systemic factor (Gafni, Weise et al. 
2001; Weise, De-Levi et al. 2001) (Fig. 3). 
 
   Fig. 3. Structural changes during growth plate senescence. Adapted from Nilsson O., 2004. 
 
First, an overall decrease in the total height of the growth plate, as well as of each 
individual zone, is observed. This phenomenon is accompanied by a decline in the 
number of proliferative and hypertrophic chondrocytes per column, more widely 
spaced columns, and smaller size of the hypertrophic cells (Kember 1973). In addition, 
an age-dependent increase in apoptosis of hypertrophic chondrocytes has been reported, 
and might contribute to the age-dependent decline in growth rate (Chrysis, Nilsson et 
al. 2002).  
The senescence program of growth plate is primarily marked by a decline of the 
proliferation rate of chondrocytes (Kember 1979).  In vivo transplantation of growth 
plates between rabbits of different ages results in different growth rates in the recipient. 
The growth rates of transplanted growth plates are dependent on the age of the donor 
animal, i.e., younger donors lead to a higher growth rate in both young and older 
recipients (Stevens, Boyer et al. 1999). This study indicates that the age-dependent 
decline in growth rate is due to a mechanism that is intrinsic to the growth plate rather 
than to a systemic mechanism. This intrinsic mechanism has been referred to as 
‘growth plate senescence’ (Baron, Klein et al. 1994).  
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1.3.3 Growth Plate Fusion & Final Height 
In humans, and most mammals, cessation of growth is accompanied by the fusion of 
the epiphysis and metaphysis, as the growth plate is ossified. Epiphyseal fusion is an 
active process with its own hormonal control, cellular mechanisms, and structural 
features. For a long time, epiphyseal fusion was believed to be the cause of cessation of 
growth (Wilkins 1965; Parfitt 2002). However, it has been clear that the growth plate 
narrows not because cartilage replacement occurs earlier, but because cartilage addition 
occurs more slowly as the rate of chondroblast proliferation declines (Walker and 
Kember 1972). Thus, the growth plate does not begin to disappear until proliferation 
has stopped altogether. Estrogens are a key component in the control of physis fusion in 
both sexes (Grumbach 2004). For more detail on its role in growth plate closure, refer 
to the section of hormonal regulation of growth plate by Sex hormones (section 
1.4.1.2).  
1.3.4 Catch-Up Growth 
Following remission of diverse chronic diseases that affect growth development, 
“Catch-up growth” may occur, which is a phenomenon characterized by height velocity 
above the normal limits for age. As a result, final height is improved, although this 
recovery of height might be complete or not (Gafni and Baron 2000). Two principal 
hypotheses have been proposed to explain the mechanism of catch-up growth. The 
‘neuroendocrine’ hypothesis postulates a central nervous system mechanism that 
compares actual body size with an age-appropriate set-point and then adjusts growth 
rate accordingly (Tanner 1963). However, evidences that growth inhibition in a single 
growth plate is followed by local catch-up do not support the neuroendocrine model 
(Baron, Klein et al. 1994). Thus, a new hypothesis that places the mechanism within the 
growth plate itself has been proposed. Accordingly to this model, growth-inhibiting 
conditions decrease proliferation of growth plate “stem-like” cells and, as consequence, 
preserve their proliferative potential. Experiments analyzing the catch-up growth of 
animals after treatment of growth-inhibiting conditions, such as hypercortisolism and 
hypothyroidism, reveal that after the growth-inhibiting condition resolves the growth 
plates are less senescent and therefore grow more rapidly than normal for age (Gafni, 
Weise et al. 2001; Marino, Hegde et al. 2008). During catch-up, animals treated from 
hypothyroidism presented a delayed decline not only in their growth plate function and 
structure, but in molecular markers of growth plate senescence as well (Gafni, Weise et 
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al. 2001; Marino, Hegde et al. 2008). Therefore inhibition of growth by different 
conditions delay the developmental program of growth plate senescence, ‘holding’ the 
finite proliferative capacity of growth plate chondrocytes on ‘standby’ state, which, at 
least partly, explain the phenomenon of catch-up growth. The molecular mechanisms 
controlling the program of growth plate senescence is just starting to unravel, but will 
explain the observed decline in growth rate of growth plate cartilage, and may also give 
insight to the simultaneous decline in growth rate of other tissues during postnatal 
growth. 
 
1.4 CONTROL OF GROWTH & DEVELOPMENT 
1.4.1 Hormonal Regulation of Growth Plate Cartilage 
A network of hormones is required for normal growth and development during 
childhood and adolescence. In healthy children, these hormones are produced in 
appropriate amounts. Only when their circulating levels are too low or to high for 
prolonged periods will there be an adverse effect on height.  In this section, we will 
briefly discuss the systemic control of growth by the major hormones: the growth 
hormone (GH), thyroid hormones (T3), Glucocorticoids (GCs) and sex hormones 
(Estrogen and Androgens), but focusing our discussion on their local regulation in the 
growth plate (Fig. 4). 
1.4.1.1 GH-Insulin-like Growth Factors (IGFs) signaling 
Growth hormone (GH) is perhaps the most well studied hormone with established 
effects on longitudinal growth. In an orchestrated network with insulin-like growth 
factors, IGF1 and IGF2, and their receptors, GH is believed to be the key regulator of 
overall linear growth. As an example, enhanced GH secretion caused by a pituitary 
adenoma in childhood leads to gigantism (Sotos 1996; Eugster and Pescovitz 1999); 
while any defects in its synthesis, release or local action results in severe dwarfism 
(Rosenfeld 2005). Thus, targeted ablation of the GH receptor (GHR), IGF1, IGF2, or 
type1-IGF receptor (IGFR1) impairs bone growth (Walenkamp and Wit 2007). 
GH acts both directly and indirectly in the growth plate chondrocytes. Gene expression 
of GH-IGF system in growth plate cartilage by diverse techniques has revealed that 
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GHR, IGF1, IGF2 and most of IGF binding proteins (IGFBPs) are detected in growth 
plate chondrocytes in several species (Nilsson, Carlsson et al. 1990; Shinar, Endo et al. 
1993; Wang, Wang et al. 1995; Reinecke, Schmid et al. 2000; Parker, Hegde et al. 
2007).   
 
Fig. 4. Hormonal Regulation of Growth Plate Cartilage by major hormones: GH-IGF1, GCs, T3, 
and sex hormones. Positive (+) and negative (-) effects on target organs are shown. Systemic 
regulation: orange color (dash lines). Direct effect on growth plate cartilage: orange color (full 
line), if positive; or red line, if negative effect on chondrocytes proliferation and differentiation. 
At the systemic level, pituitary GH acts on the liver to generate IGF1 that acts as an 
endocrine factor that stimulates longitudinal bone growth. The role of circulating IGF1 
has been supported by the two following complementary studies. Liver-specific 
knockout of IGF1 in mice reduce circulating IGF1 levels by approximately 75%, 
without appreciable effect on postnatal growth, suggesting that the remaining bioactive 
IGF1 levels were enough to preserve longitudinal growth (Liu, Yakar et al. 2000). In 
addition, double knockout of liver-specific IGF1 and acid-labile sub-unit (ALS), a 
component of the circulating IGF1 complex required for bioactivity of  IGF1, further 
reduces the levels of circulating IGF1, and caused inhibition of linear growth and 
decreased height of the growth plate (Yakar, Rosen et al. 2002). Furthermore, IGF1 
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treatment of mice and human with inactivating mutation on GHR markedly improve 
their linear bone growth, supporting the positive role of circulating IGF1 on linear 
growth (Guevara-Aguirre, Rosenbloom et al. 1997; Sims, Clement-Lacroix et al. 2000). 
Direct injection of GH into the tibial growth plate accelerates longitudinal growth in the 
injected growth plate compared to the contra-lateral control-tibia, reassuring their direct 
role in growth plate (Isaksson, Jansson et al. 1982). Parker et al. have detected GHR 
expression with similar levels in all zones of rat growth plate (Parker, Hegde et al. 
2007). At the local level, GH appears to act locally not only in the resting zone of the 
growth plate, rescuing them into a proliferative state (Ohlsson, Nilsson et al. 1992), but 
also by stimulating local IGF1 production in proliferative and hypertrophic zones 
(Schlechter, Russell et al. 1986; Hunziker, Wagner et al. 1994; Wang, Zhou et al. 
1999). Interestingly, double knockout of GHR and IGF1 results in mutant mice smaller 
than single gene knockouts, indicating that GH and IGF1 co-interact positively by 
promoting longitudinal growth (Wang, Zhou et al. 1999; Lupu, Terwilliger et al. 2001). 
These findings are consistent with the ‘dual effector hypotheses’ of GH in the growth 
plate cartilage. One interesting observation is the absence or very low level of IGF1 
mRNA expression throughout all zones of the growth plate, suggesting that local IGF1 
may not be produced by growth plate chondrocytes, but most likely come from 
surrounding tissues, i.e. perichondrium or bone (Parker, Hegde et al. 2007).  
On the other hand, IGF2 has been found at high levels in the growth plate, especially in 
resting and proliferative chondrocytes, suggesting its role in regulation of cell 
proliferation (Parker, Hegde et al. 2007). IGF2 is a positive regulator of prenatal 
growth, independent of GH. However, during postnatal growth, its role remains 
unclear. The finding that IGF2 expression declines by a thousand-fold in growth plate 
and surrounding tissues during a period of rapidly declining growth rate (Parker, Hegde 
et al. 2007) is consistent with the finding that IGF2 deficient mice present impaired 
longitudinal bone growth, primarily early in life (Jehle, Schulten et al. 2003).  In 
addition, IGF2 expression declines in multiple tissues during postnatal development of 
rodents, which may suggest a regulatory mechanism common to multiple cell types 
(Brown, Graham et al. 1986; Lund, Moats-Staats et al. 1986; Parker, Hegde et al. 
2007). 
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1.4.1.2 Estrogens 
1.4.1.2.1 Pubertal Growth Spurt 
The effect of sex steroids, estrogen and androgens, on stature depends on the age at 
which they are active, and act mostly in the natural growth acceleration during puberty 
(‘pubertal growth spurt’) and ultimately in the cessation of growth accompanied by 
epiphyseal fusion. In the presence of pathological conditions, such as sexual 
development at a precocious age, increase in sex steroids may therefore result in 
tallness at the time of steroids production, but because growth also stops prematurely, 
ultimate stature is likely to be short (Lee 2003). Conversely, when pubertal growth 
spurt is delayed, stature will fall off compared with that of contemporaries, but growth 
may continue to an older age and make up for the initial deficit, with a possible 
outcome of normal or tall stature (Butenandt and Kunze ; Zirilli, Rochira et al. 2008).   
The pubertal growth spurt has a better temporal correlation with the increase in 
estrogen levels than androgen levels (Klein, Martha et al. 1996). A near-normal growth 
spurt occurs in patients with androgen insensitivity (Zachmann, Prader et al. 1986),   
whereas little or no growth spurt occurs in patient with aromatase deficiency, an 
enzyme that converts androgen in estrogen (Rochira and Carani 2009).  
Much of the growth acceleration due to estrogen is mediated by estrogen-induced 
stimulation of the GH-IGF1 axis (Grumbach 2000). The pulses of GH secretion are 
known to increase in amplitude during puberty. In addition, estrogen treatment results 
in elevated circulating levels of GH and IGF1, whereas blocking estrogen signaling 
reduces these levels (Metzger and Kerrigan 1994; Hero, Norjavaara et al. 2005). 
Estrogens effects are modulated mainly by two nuclear receptors, estrogen receptor-α 
(ERα) (Green, Walter et al. 1986; Greene, Gilna et al. 1986) and estrogen-receptor-β 
(ERβ) (Kuiper, Enmark et al. 1996), in a complex that interacts with estrogen response 
elements (EREs) in the promoter regions of target genes and activate a variety of 
intracellular signaling cascades. A new membrane-bound G protein-coupled estrogen 
receptor (GPR30) that rapidly mediates estrogen signaling was recently identified as 
well (Revankar, Cimino et al. 2005). At the level of growth plate, the local action of 
estrogens is supported by the expression of both estrogen receptors (ERα and β) in the 
postnatal growth plate of rats, rabbits, and humans (Nilsson, Abad et al. 2002; Nilsson, 
Chrysis et al. 2003). GPR30 is also found at high levels in the hypertrophic zone of 
  
13  
growth plate, decrease during puberty, and appear to be required for normal estrogenic 
responses in the growth plate, contributing to modulate pubertal bone growth (Chagin 
and Savendahl 2007).  
1.4.1.2.2 Epiphyseal Fusion 
Estrogens are a key component in the control of physis fusion in both sexes.  If 
deficiency of estrogen occurs, epiphyseal plate can remain unfused long after growth 
has stopped, followed by normal fusion as long as the missing hormone is replaced 
(Grumbach 2004). Patients with genetic mutation in either the gene encoding the 
aromatase enzyme that converts androgen to estrogen (Morishima, Grumbach et al. 
1995), or in the gene encoding the estrogen receptor-α (Smith, Boyd et al. 1994) fail to 
close their physes at the time of sexual maturation, and show evidence of increased 
height due to longitudinal bone growth into adulthood. Conversely, patients who are 
exposed to estrogen prematurely close their physes earlier than predicted, such as in 
precocious puberty. 
At the local level, estrogen may affect senescence by acting directly on growth plate 
chondrocytes. Both types of estrogen receptors (ERα and β) have been detected in 
postnatal growth plate of rats, rabbits, and humans (Nilsson, Abad et al. 2002; Nilsson, 
Chrysis et al. 2003). In particular, ERs in resting zone might mediate the long-term 
estrogenic effect on growth plate senescence and epiphyseal fusion (Nilsson and Baron 
2004). The mechanism by which estrogen controls epiphyseal fusion is not fully 
understood. The current concept is that estrogen does not stimulate the ossification of 
cartilage directly, but it accelerates the normal process of growth plate senescence, 
which secondarily causes earlier fusion (Weise, De-Levi et al. 2001). In humans, this 
hypothesis may explain why the timing of estrogen-mediated fusion depends on the age 
of the individual. Exposure of estrogen, as seen in precocious puberty, may take up to 
10 years if it occurs during early childhood; or only a few months, if it occurs later 
during adolescence (Sigurjonsdottir and Hayles 1968; Carani, Qin et al. 1997; 
Bilezikian, Morishima et al. 1998). This temporal association indicates that fusion is 
triggered when the proliferative potential of growth plate chondrocytes is exhausted 
(Nilsson and Baron 2004). In a young child, there would be a large proliferative 
capacity, which requires longer time of estrogen exposure until exhaustion of the 
replicative capacity of the growth plate has been reached.  On the other hand, the 
proliferative capacity in the growth plate of ‘older individuals’ is far less; and requires a 
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shorter exposure to estrogen until complete exhaustion is achieved (Nilsson and Baron 
2004).  
1.4.1.3 Androgens 
Androgens also contribute to the pubertal growth spurt, to a lesser extent than 
estrogens, by mechanisms not fully explained. During puberty, like estrogens, 
testosterone stimulates the GH-IGF1 axis, whereas non-aromatizable androgens don’t, 
suggesting that androgens ‘per se’ stimulate pubertal growth through other mechanisms 
in a GH-independent manner (Keenan, Richards et al. 1993). Local administration of 
testosterone in growth plate cartilage increases unilateral rat tibial growth plate width, 
suggesting the local action of testosterone, independent of GH (Ren, Malozowski et al. 
1989). However, these local effects may be partially mediated by an increase in local 
IGF1 expression (Maor, Segev et al. 1999; Krohn, Haffner et al. 2003).  
In fact, most of androgen effects on growth are probably due to aromatization into 
estrogens in peripheral tissues, possibly in growth plate as well. Recent study by 
Chagin et al. show that oxandrolone does not influence the linear growth of cultures of 
fetal rat metatarsal bones and support the hypothesis that androgens affect linear growth 
mainly after being aromatized to estrogen locally in the growth plate (Chagin, Vannesjo 
et al. 2009). This hypothesis is supported by findings of  aromatase P450 (CYP19) (Oz, 
Millsaps et al. 2001; van der Eerden, Lowik et al. 2004) and androgen receptor (AR) 
(Abu, Horner et al. 1997; van der Eerden, van Til et al. 2002; Nilsson, Chrysis et al. 
2003) expression in the growth plate of different species, including rat and humans. 
1.4.1.4 Thyroid Hormones 
Thyroid hormones, thyroxin (T4) and triiodothyronine (T3) are primarily responsible 
for proper development and differentiation of all cells in the human body. They are 
determinant for postnatal somatic growth, including longitudinal bone growth 
(Williams, Robson et al. 1998). Fundamentally, thyroid hormone signaling results 
from the interaction of nuclear thyroid hormone receptors (TRs) with specific target 
gene promoters, a process that can either enhance or repress transcription. The 
underlying mechanism of these phenomena is deiodination. The iodothyronine 
deiodinase type II (D2) generates the active form of thyroid hormone T3 via 
deiodination of T4. Untreated hypothyroidism in children, either congenital or 
acquired, may result in severe growth retardation and delayed skeletal maturation 
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(Rivkees, Bode et al. 1988; Leger and Czernichow 1989). In contrast, 
hyperthyroidism in children is associated with accelerated growth rate and skeletal 
maturation, and although it is accompanied by tall stature at an earlier stage of the 
disease, ultimately result in normal predicted stature (Buckler, Willgerodt et al. 1986; 
Kvistad, Lovas et al. 2004). In hypothyroid rats, the growth plate show a decrease in 
the heights of both proliferative and hypertrophic zones, accompanied by a decline in 
chondrocyte proliferation and hypertrophy, vascular invasion and mineralization. 
Moreover, the normal columnar organization of the growth plate is disrupted 
(Stevens, Hasserjian et al. 2000).  
Thyroid hormone regulates linear growth through different mechanisms. In vivo 
studies suggest that T3 may stimulate longitudinal growth by increasing GH-IGF1 
secretion (Kindblom, Gothe et al. 2001). Skeletal abnormalities in TRα1-/- and β-/- are 
associated with inhibition of the GH–IGF1 axis, and growth retardation is reversed by 
GH replacement, but it does not rescue the growth plate ossification abnormalities 
(Kindblom, Gothe et al. 2001). These findings suggest that thyroid hormone also 
exert direct effects on the skeleton.  
The direct effect of T3 on the growth plate and bone is supported by the expression of 
the α1, α2, β1 and β2 isoforms of T3 receptors (TR) in chondrocytes and osteoblasts 
(Abu, Bord et al. 1997; Ballock, Mita et al. 1999; Abu, Horner et al. 2000). In rat 
growth plate, TRs proteins are expressed in resting and proliferating zone 
chondrocytes but not in the hypertrophic zone (Robson, Siebler et al. 2000; Stevens, 
Hasserjian et al. 2000). However, in humans, both mRNA and protein of all isoforms 
of TRs are widely distributed in each zones of the growth plate (Abu, Bord et al. 
1997; Abu, Horner et al. 2000). In addition, the expression of iodothyronine 
deiodinase type II (D2) in the growth plate suggests that local conversion of T4 to T3 
by this enzyme may contribute to local effects of T3 in the growth plate (Miura, 
Tanaka et al. 2002; Shen, Berry et al. 2004; Capelo, Beber et al. 2008). However, the 
precise localization of T3-responsive cells within the growth plate and their target 
genes remains unknown. 
 The generation of transgenic mice lacking different types of TRs has enlightened 
their functional roles in growth plate and longitudinal growth (O'Shea and Williams 
2002). Deletion of all TRα isoforms (TRα0/0) result in linear growth retardation, 
disorganization of the normal columnar architecture, impaired chondrocyte 
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hypertrophy and delayed mineralization of growth plates chondrocytes (Gauthier, 
Plateroti et al. 2001), as it is featured in growth plate of hypothyroid mice (Stevens, 
Hasserjian et al. 2000). On the other hand, selected deletion of all isoforms of TRβ 
(TRβ-/-) result in no growth retardation or skeletal phenotype, suggesting that TRα, 
but not TRβ, is the predominant TR governing endochondral ossification (Gauthier, 
Plateroti et al. 2001).  
Surprisingly, the majority of human cases of thyroid hormone resistance are caused 
by dominant-negative mutations in the TRβ gene. These mutations cause a frame shift 
in the ligand-binding domain (TRβPV), resulting in the loss of T3 binding affinity and 
reduced transcriptional activation (Weiss and Refetoff 2000). In addition, these 
mutations may affect TRα function as well, with variable skeletal effects (Takeda, 
Sakurai et al. 1992; Olateju and Vanderpump 2006). Treatment of hypothyroid rats 
with GC-1, a synthetic analog of TH that selectively binds and activates TRβ over 
TRα while retaining the same binding affinity as T3, failed to normalize longitudinal 
growth and structural abnormalities in growth plate (Freitas, Capelo et al. 2005). 
However, the same study showed normalized differentiation of hypertrophic 
chondrocytes, type X collagen expression, and growth plate thickness of treated 
animals, suggesting that some essential effects of thyroid hormone on bone growth 
may be mediated by TRβ as well (Freitas, Capelo et al. 2005). 
 
1.4.1.5 Glucocorticoids  
Glucocorticoids (GCs) excess is one of the commonest conditions associated with 
growth retardation, but rarely due to pituitary or adrenal disease in childhood. 
Hypercortisolism is more commonly the result of high dosage GCs treatment of 
several conditions during growth development, such as juvenile arthritis, chronic 
asthma and nephrotic syndrome (Allen 1996; Savage, Scommegna et al. 2002). 
Conversely, familial GC deficiency syndrome is correlated with tall stature, 
suggesting that GCs act as negative regulator of longitudinal growth at normal levels 
(Chung, Chan et al. 2010).  
Expression of the glucocorticoid receptor (GR) gene has been demonstrated in rat and 
human growth plate chondrocytes (Abu, Horner et al. 2000; Silvestrini, Ballanti et al. 
2000), suggesting their local action as well. Supporting this hypothesis, systemic 
administration of GC in several species reduces tibial length and growth plate width 
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(Altman, Hochberg et al. 1992; Silvestrini, Ballanti et al. 2000; Gafni, Weise et al. 
2001).  Moreover, local infusion of dexamethasone in one growth plate suppresses 
growth in the infused leg compared to the vehicle-treated contra-lateral leg (Baron, 
Huang et al. 1992).  Smink and collaborators showed that even short term treatment 
with GCs in mice lead to growth retardation, decreased growth plate width, with 
decreased rate of chondrocytes proliferation and increased apoptosis in hypertrophic 
zone, accompanied by a reduction in the local level of IGF1 (Smink, Gresnigt et al. 
2003). 
Altogether, these observations suggest that the local and suppressive effects of GCs 
appear to occur mainly through a potent suppression of chondrocyte proliferation 
(Annefeld 1992; Smink, Gresnigt et al. 2003), and possibly due to an increase in 
apoptosis of hypertrophic chondrocytes in the growth plate (Chrysis, Ritzen et al. 
2003; Smink, Gresnigt et al. 2003). However, altered GH/IGF1 system may not be 
excluded as a potential additional mechanism. 
 
1.4.2 Local (Paracrine/ Autocrine) Regulation of Growth Plate Cartilage 
A multitude of signaling mechanisms are required to maintain spatial organization 
and optimal balance between chondrocyte proliferation and differentiation within the 
growth plate cartilage. To date, several signaling pathways that control the 
endochondral ossification are well-established, especially during early 
chondrogenesis; since most of the studies have been performed in embryonic models. 
A growing body of evidence suggests that many of the genes important for embryonic 
skeletogenesis and still unknown genes, also play an important role during postnatal 
growth. However, how these distinct molecules interact to coordinate postnatal bone 
development is not well understood. This section will focus on the study of a number 
of transcription factors and genes that we are known to regulate endochondral 
ossification at the level of the growth plate, giving close attention to its regulation 
during postnatal growth.  
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1.4.2.1 Transcription Factors 
1.4.2.1.1 SOX9 
SOX9 (SRY (sex determining region Y)-box 9) is a critical factor for all phases of the 
chondrocyte lineage, from early condensations to the conversion of proliferating 
chondrocytes to hypertrophic chondrocytes, and also determines the fate of MSC 
condensations into collagen type II expressing chondrocytes(Lefebvre and de 
Crombrugghe 1998; Zhou, Lefebvre et al. 1998; Lefebvre and Smits 2005). In humans, 
SOX9 mutations cause the rare condition campomelic dysplasia (CD) characterized by 
severe dwarfism, bowing and angulations of long bones among other skeletal 
anomalies (Foster, Dominguez-Steglich et al. 1994; Wagner, Wirth et al. 1994). These 
skeletal anomalies are consequent to a defect in chondrocyte differentiation within 
MSC condensations and decreased synthesis of cartilage matrix. Selective SOX9 
knockout from early limb mesenchyme by using a Cre-loxP strategy, results in the 
absence of cartilage condensations and increased apoptosis in the mesenchyme 
(Akiyama, Chaboissier et al. 2002).  
At later stages, overexpression of SOX9 in mice results in growth plates with a shorter 
proliferative zone, decreased chondroblast proliferation and Cyclin D1 expression, 
which is required for optimal proliferation (Akiyama, Lyons et al. 2004). Furthermore, 
SOX9 appears to delay the pre-hypertrophy of chondrocytes, since SOX9+/- mouse 
fetuses feature prematurely mineralized cartilages and expanded hypertrophic zones in 
their growth plate (Bi, Deng et al. 1999). The molecular mechanism of SOX9 
regulation is not fully understood. There is evidence that SOX9 may regulate 
chondrocyte differentiation, proliferation and maturation by cross-talking with the 
Wnt/β-Catenin pathway, which is crucial for the differentiation of MSC directly into 
osteoblast (Akiyama, Lyons et al. 2004).  
Interestingly, while SOX9 transcripts are highly expressed throughout the fetal growth 
plate; during postnatal life, it is mainly expressed in proliferating chondrocytes and 
switched off in hypertrophic chondrocytes (Wright, Hargrave et al. 1995; Ng, Wheatley 
et al. 1997). In a recent study, development of transgenic mice misexpressing Sox9 in 
hypertrophic chondrocytes under the control of a BAC-Col10a1 promoter, shows that 
newborn mice present an almost complete lack of bone marrow strongly retarded 
vascular invasion into hypertrophic cartilage and impaired cartilage resorption. These 
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results in delayed endochondral bone formation and reduced bone growth (Hattori, 
Muller et al. 2010). In addition, suppression of VEGF expression was observed, which 
is an important factor for vascularization of terminally differentiated chondrocytes, 
suggesting that down-regulation of Sox9 in hypertrophic zone of normal growth plates 
is essential for allowing vascular invasion, bone marrow formation and also 
endochondral ossification (Hattori, Muller et al. 2010).  
1.4.2.1.2 RUNX2 (Runt-related Transcription Factor 2) 
RUNX2 (Runt-related Transcription Factor2) , previously named Cbfa1,  is expressed 
in the late condensation stage of chondrogenesis, followed by a substantial decrease in 
proliferating chondrocytes, with an increased expression again in prehypertrophic and 
hypertrophic chondrocytes. Although better known by its crucial role in differentiation 
of MSC into osteoblasts, RUNX2 is also important in the regulation of growth plate 
cartilage, by promoting differentiation of chondrocytes into hypertrophy (Komori, Yagi 
et al. 1997; Otto 1997; Inada, Yasui et al. 1999). RUNX2 knockout mice lack most 
bones and (?) present decreased numbers of hypertrophic chondrocytes, which fail to 
mineralize their matrix, and also show lower or absent expression of genes commonly 
expressed in late differentiated chondrocytes, such as osteopontin and matrix 
metalloproteinase 13 (MMP13) (Komori, Yagi et al. 1997; Otto 1997; Inada, Yasui et 
al. 1999). In addition, transgenic expression of a dominant-negative form of RUNX2 
blocks hypertrophy of all chondrocytes (Ueta, Iwamoto et al. 2001). On the other hand, 
transgenic expression of RUNX2 accelerates hypertrophy of normal chondrocytes, and 
reverses the phenotype in knockout mice (Takeda, Bonnamy et al. 2001; Ueta, Iwamoto 
et al. 2001).  
1.4.2.2 Vascular Endothelial Growth Factor (VEGF) 
Vascular endothelial growth factor (VEGF) appears to be a key factor for vascular 
invasion of the growth plate, a critical step for successful bone formation. VEGF is a 
protein that targets vascular endothelial cells, expressed exclusively in hypertrophic 
chondrocytes in the growth plate (Gerber, Hillan et al. 1999; Gerber, Vu et al. 1999; 
Horner, Bishop et al. 1999). Hypertrophic chondrocytes also express the VEGF 
receptor, suggesting that this factor may have an autocrine role in these cells 
(Carlevaro, Cermelli et al. 2000). Inhibition of VEGF function by the use of an oral 
inhibiting agent (ZD4190) (Wedge and Ogilvie 2000), or by the administration of a 
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soluble receptor chimeric protein (Flt-(1-3)-IgG) that block activation of the receptor 
for VEGF (Gerber, Vu et al. 1999), leads to loss of vascular invasion, resulting in 
profound disturbances in the architecture of the growth plate. Calcified cartilage 
persists due to a decrease in the resorption of terminally differentiated chondrocytes, 
resulting in widening of hypertrophic region and in the decrease of trabecular bone 
formation. Conversely, after cessation of anti-VEGF treatment, the growth plate 
structure and function return to a normal state, with resumption of capillary invasion, 
restoration of bone growth, and resorption of hypertrophic chondrocytes.  
Several studies show evidence that other factors mentioned previously, such as Ihh, 
RUNX2, BMPs   and Sox9 are implicated in the regulation of terminal differentiation 
and angiogenesis of the growth plate through the modulation of VEGF expression   
(Gerber, Vu et al. 1999; Horner, Bishop et al. 1999; Hattori, Muller et al. 2010). 
Moreover, growth plate specific targeted deletion of a transcription factor known as 
hypoxia inducible factor (HIF-1α) that regulates VEGF expression in the embryonic 
growth plate, promoted increased cell death and reduced VEGF expression (Schipani, 
Ryan et al. 2001).  
1.4.2.3 Indian Hedgehog / Parathyroid Hormone-related Peptide 
(Ihh/PTHrP) Signaling 
Indian hedgehog (Ihh) is considered to be a master regulator of chondrocytes 
proliferation (Kronenberg 2003). Ihh belongs to the 3-member family of hedgehog 
proteins, including Desert hedgehog and Sonic hedgehog, the latter of which is one of 
the main regulators of limb outgrowth (McGlinn and Tabin 2006). Expressed mainly 
by prehypertrophic and early hypertrophic chondrocytes (Vortkamp, Lee et al. 1996), 
Ihh binds to a receptor called patched (Ptc), which activates Smoothened (Smo), a 
membrane protein that triggers a cascade resulting in gene activation. Knockout of Ihh 
in mice (Ihh-/-) result in normal skeletogenesis at the condensation stage, but is followed 
by abnormalities of bone growth mainly due to a decrease in chondrocyte proliferation 
(St-Jacques, Hammerschmidt et al. 1999). In addition, Smo knockout also leads to 
decreased proliferation of chondrocytes (Long, Zhang et al. 2001). Conversely, 
overexpression of either Ihh or Smo specifically in cartilage increases proliferation, 
suggesting that the Ihh signaling pathway is sufficient to promote chondrocyte 
proliferation (Long, Zhang et al. 2001).  
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Another unusual feature of Ihh null mice is an increase in the population of 
hypertrophic chondrocytes, which is due to a premature exit of cells from the pool of 
proliferating chondrocytes. The rate at which growth plate chondrocytes leave the 
proliferative zone and commit to terminally differentiated hypertrophic cells is 
controlled by an orchestrated feedback loop involving Ihh and parathyroid hormone-
related peptide (PTHrP), currently named parathyroid hormone-like peptide (PTHLP) 
(Vortkamp, Lee et al. 1996). A constitutive activation of PTH/PTHrP receptors (PPRs) 
reverses the early hypertrophy observed in Ihh null mice, but does not reverse the 
decreased proliferation observed in their growth plates (Karp 2000). These findings 
indicate that Ihh signaling regulates chondrocytes maturation and hypertrophy through 
PTHrP, but may act independently of PTHrP with regards to chondrocyte proliferation.   
A third striking abnormality in Ihh knockout mice is the absence of osteoblasts in either 
the primary spongiosa or the bone collar of long bones, suggesting that Ihh may also 
control osteoblasts differentiation. Chimaeric experiments where PPR knockout 
chondrocytes, mixed with wild-type chondrocytes, show ectopic osteoblast formation 
adjacent to the ectopically positioned hypertrophic chondrocytes. On the contrary, in 
double PPR/Ihh- knockout mice, ectopic bone was absent (Chung, Lanske et al. 1998; 
Chung, Schipani et al. 2001). Hence, Ihh not only controls the differentiation of 
osteoblasts, but also determines the location where the bone collar is formed, precisely 
at the transition between chondrocytes proliferation and hypertrophy (Kronenberg 
2003). 
PTHrP belongs to the calcium-regulating parathyroid hormone (PTH) family. It is 
expressed mainly by periarticular and early proliferative chondrocytes of the growth 
plate and plays a crucial role in keeping proliferating chondrocytes in the proliferative 
stage (Juppner, Abou-Samra et al. 1991; Vortkamp, Lee et al. 1996). On the other hand, 
its receptor is a G-protein-coupled receptor that is also shared by PTH and is localized 
primarily in the lower proliferative and prehypertrophic zones (Karaplis 1994; 
Vortkamp, Lee et al. 1996). In humans, mutations in the PTH/PTHrP receptor (PPR) 
that result in a constitutively active PTHrP signal are responsible for Jansen’s 
metaphyseal chondrodysplasia, a dwarfing disorder associated with delayed growth 
plate mineralization and hypercalcemia (Schipani, Langman et al. 1996). Interestingly, 
knockout of either, PTHrP (Karaplis 1994) or PPR (Lanske, Karaplis et al. 1996) 
causes severe dwarfism in mice and accelerated chondrocyte hypertrophy. Conversely, 
  
22 
overexpression of PTHrP (Weir 1996) or expression of a constitutively active PPR 
(Schipani 1997) in the growth plate inhibits chondrocyte differentiation.  
Altogether, these transgenic models and selected clinical cases confirm the important 
role of Ihh and PTHrP in the control of growth plate chondrocyte proliferation and 
differentiation during fetal life. In summary, it has been proposed that PTHrP secreted 
from periarticular chondrocytes acts on its receptor (PPR) localized on proliferating 
chondrocytes to keep them proliferating, and thereby delays the production of Ihh. As 
new chondrocytes are formed through proliferation in the upper part of the proliferative 
zone, chondrocytes in the lower part of the proliferative zone become sufficiently 
distant from the source of PTHrP to the point where they are no longer stimulated by 
the protein. Only then do they stop proliferating, start to hypertrophy, and synthesize 
Ihh. Ihh subsequently acts on adjacent proliferative chondrocytes to promote 
proliferation and, through mechanisms not yet fully understood, stimulate the 
production of PTHrP in periarticular chondrocytes (Kronenberg 2003). 
Several studies have shown that Ihh, PTHrP and their receptors are also expressed in 
the postnatal growth plate, indicating that Ihh-PTHrP signaling may continue to be 
beyond embryonic longitudinal bone growth (Vortkamp, Lee et al. 1996; van der 
Eerden, Karperien et al. 2000; Farquharson, Jefferies et al. 2001; Nakase, Miyaji et al. 
2001). In addition, targeted expression of constitutively active PPRs in the growth 
plates of mice lacking PTHrP  rescue their growth plate phenotype at birth and result in 
prolonged postnatal survival of PTHrP null mice by up to two months (Schipani 1997). 
After birth, however, these "rescued" animals grow less than their control littermates, 
and show premature disappearance of their growth plates and secondary ossification 
centers (Schipani 1997). These finding indicate that PTHrP is involved in the control of 
growth plate chondrocyte differentiation both during embryonic and postnatal life. 
1.4.2.4 Bone Morphogenetic Proteins (BMPs) 
Bone morphogenetic proteins (BMPs) were first identified due to their ability to induce 
ectopic bone formation, and have later been shown to be essential for multiple stages of 
skeletal development and endochondral ossification, including early patterning and 
mesenchymal cell condensation as well as regulation of chondrocyte proliferation and 
maturation in the growth plate (Urist 1965; Pogue and Lyons 2006). BMPs are multi-
functional growth factors that belong to the transforming growth factor β (TGF-β) 
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Superfamily. To date, around 20 BMP family members have been identified, where 
only BMPs 2 to 7 belong to the TGF-β superfamily. Three type I receptor transducer 
BMP signals (type IA, IB, and ALK-2),  through the formation of heteromeric 
complexes with threonine kinase receptors, leading to the activation of the canonical 
Smad pathway, as well other pathways (Derynck and Zhang 2003).  
BMP signaling is required as part of an instructive signal to promote commitment of 
mesenchymal cells to the chondrogenic lineage. BMP1a and BMP1b receptors 
knockout mice lack the majority of skeletal elements that form through endochondral 
ossification (Yoon, Ovchinnikov et al. 2005). Contrarily, mice deficient in the BMP 
antagonist Noggin have multiple skeletal abnormalities, including enlarged growth 
plates, presumable due to loss of opposition to BMP signaling (Brunet, McMahon et al. 
1998), and overexpression of constitutively active BMP receptors results in the 
expansion of cartilage (Pizette and Niswander 2000). One potential mechanism is 
through the maintenance of SOX9 expression in MSC condensations, the earliest 
known marker for cells committed to chondrogenesis. In vitro, BMPs promote the 
expression of SOX9 in cell cultures, and its expression is required for BMP induced 
chondrogenesis, as antisense SOX9 oligonucleotides block the ability of BMPs to 
induce type II collagen (Zehentner, Dony et al. 1999; Fernandez-Lloris, Vinals et al. 
2003). In vivo, implantation of BMP2 beads near condensed cartilage leads to up-
regulation of the Sox protein in condensation, while beads of the BMP antagonist 
Noggin lead to its severe down-regulation (Chimal-Monroy, Rodriguez-Leon et al. 
2003).  In addition, overexpression of Noggin blocks MSC condensation, leading to a 
total absence of cartilage (Capdevila and Johnson 1998).  
During later stages of chondrogenesis, BMP signaling appears to promote hypertrophic 
chondrocyte differentiation (De Luca, Barnes et al. 2001).  Expression of different 
BMPs members have specific pattern in the growth plate (Yoon and Lyons 2004; 
Nilsson, Parker et al. 2007). BMP-6 and Bmpr1a is highly expressed in hypertrophic 
chondrocytes in both, the embryonic and postnatal growth plate. BMP-2,-4, and -5 has 
been detected in the perichondrial cells of embryonic growth plates. BMP-2 was 
detected at higher levels in the hypertrophic zone of the postnatal growth plate. BMP-7 
is mainly expressed in proliferating chondrocytes. On the other hand, expression of 
gremlin, chordin, and BMP-3, all inhibitors of BMP-induced bone formation, are up-
regulated in the resting zone of the postnatal growth plate. The expression pattern in the 
postnatal growth plate suggests that there is a gradient in BMP-signaling created by the 
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expression of BMP agonists primarily in hypertrophic zone, and the BMP antagonist in 
resting as well as proliferative zones in the growth plate (Nilsson, Parker et al. 2007). 
Altogether, these studies point to a contribution of BMPs in both proliferation and 
differentiation of the growth plate chondrocytes during pre- and postnatal growth. 
The diverse functions of the BMP signaling pathway in the growth plate are directly or 
indirectly correlated to its interactions with other signaling pathways. Two important 
interactions are with the Ihh/PTHrP and FGF signaling pathways. BMPs interact with 
the Ihh/PTHrP pathway by promoting Ihh expression, which maintains BMP levels, 
indicating the existence of a positive feedback loop between them (Kawai and Sugiura 
2001; Minina 2001). However, neither pathway completely mediates the other’s 
functions and both act more in a synergistic way. On the contrary, BMPs and FGFs 
show functional antagonism in the regulation of chondrocytes. BMP treatment rescues 
the phenotype of FGF treated growth plates, and FGF treatment neutralizes the effects 
of BMPs (Minina, Kreschel et al. 2002). The mechanisms underlying this antagonism 
are not well understood, but may in part be due to opposite effects on Ihh production by 
hypertrophic chondrocytes (Naski, Colvin et al. 1998; Minina, Kreschel et al. 2002). 
Further functional studies are needed to clarify the interaction of these factors in the 
regulation of growth plate cartilage.  
1.4.2.5 Fibroblast Growth Factors (FGFs) 
Fibroblast growth factors (FGFs) comprise a family of at least 22 secreted proteins that 
interact with differing affinities to one of the four high-affinity FGF receptors (FGFR) 
(Ornitz and Marie 2002). Opposite to Ihh/PTHrP and BMP signaling, FGFs provide 
essential inhibitory signals in the control of chondrocyte proliferation.  
Point mutations, G to A (99%) or G to C (1%),  at nucleotide 1138 of the FGFR3 gene 
activate the FGF receptor 3 (FGFR3) and cause achondroplasia (ACH), the most 
common genetic form of dwarfism in humans, characterized by reduced growth of long 
bones with proximal elements more severely affected than distal ones (Rousseau, 
Bonaventure et al. 1994). In mice, an activating point mutation in the FGFR3 decreases 
the rate of chondrocyte proliferation and lead to shortened and disorganized columns in 
their growth plates  (Naski, Colvin et al. 1998). Conversely, FGFR3 knockout leads to 
an opposite phenotype, with an increased rate of chondrocyte proliferation and length 
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expansion of chondrocyte columns (Colvin, Bohne et al. 1996; Deng, Wynshaw-Boris 
et al. 1996).  
Many other human skeletal dysplasias have been attributed to a specific mutation in the 
genes encoding FGF receptors (Muenke and Schell 1995). As an example, the bony 
syndactyly resulting from mutations in FGFR2 in Apert syndrome may result from 
defects in signaling in the mesenchymal condensation. The Apert mutations result in a 
loss of ligand binding specificity, which allow inappropriate activation of FGFR2 by 
the ligands (e.g. FGF7) expressed in the MSC condensation, as well as through 
inappropriate activation of FGFR2b by other ligands such as FGF2, FGF6, and FGF9 
(Yu, Herr et al. 2000; Yu and Ornitz 2001).  
However, the role of FGF signaling in the condensing mesenchyme is poorly 
understood. It is possible that FGF signaling induces the expression of SOX9 
(Murakami, Kan et al. 2000). Another possible mechanism of FGFs is by interacting 
with IHH/PTHrP signaling. Knockout of the FGFR3 gene increases Ihh expression and 
activating mutation of FGFR3 decreases its expression (Naski, Colvin et al. 1998; 
Ornitz and Marie 2002). Moreover, in vitro studies support the idea that FGFs inhibit 
chondrocyte proliferation by suppressing Ihh expression (Minina, Kreschel et al. 2002). 
FGFs expression pattern has been shown in chicken, mouse and human limb 
development (Peters, Werner et al. 1992; Szebenyi, Savage et al. 1995; Delezoide, 
Benoist-Lasselin et al. 1998). FGFR2 expression is the first observed in the MSC 
condensation center of the developing limb. At the condensation step, FGFR1 
expression is found in the periphery of the mesenchymal condensations. Later, FGFR1 
and FGFR2 expression persists in the perichondrium and periosteum. As the epiphyseal 
growth plate is formed, FGFR1 expression is initiated and maintained mainly in 
hypertrophic chondrocytes (Deng, Wynshaw-Boris et al. 1994). In contrast, FGFR3 
expression is first observed  in the condensation center,  as chondrogenesis begins, and 
later, is mainly expressed in the proliferating chondrocytes (Peters, Ornitz et al. 1993).  
On the contrary, several of the FGFs ligands are expressed in the developing 
endochondral bone.  Interestingly, expression of FGFs 7, 8, 17, and 18 has been 
observed in the perichondrium (Mason, Fuller-Pace et al. 1994; Finch, Cunha et al. 
1995; Xu, Liu et al. 2000; Liu, Xu et al. 2002), suggesting a possible paracrine signal to 
the growth plate. However, knockout studies reveal that only the lack of FGF18 results 
in abnormal chondrogenesis. FGF18 null mice show increased chondrocyte 
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proliferation, delayed ossification and decreased VEGF expression in the hypertrophic 
zone and perichondrium, suggesting that FGF18 contributes to the coordinated 
neovascularization of the growth plate, besides regulating chondrocyte proliferation 
(Liu, Lavine et al. 2007). In addition, the similarity between the phenotypes of FGF18 
and FGFR3 knockout mice suggest that FGF18 may be the natural ligand responsible 
for inhibition of proliferation through FGFR3. However, the more severe phenotype of 
FGF18 null mice suggests that FGF18 signals through other FGF receptors. It is 
possible that the redundancy of ligands (FGFs) combined with the multiple early effects 
of FGF receptors in bone development may compensate for individual FGFs mutations. 
Characterization of FGF and FGFR expression in microdissected growth plate cartilage 
from postnatal rat using real-time PCR detected high levels FGFR1-3, especially 
isoform C, whereas most FGFs were not detected or only detected at low levels in 
growth plate chondrocytes. FGF18 is expressed in perichondrium, and at lower levels 
in the hypertrophic and resting zones of the post-natal growth plate.  (Lazarus, Hegde et 
al. 2007). These findings thus suggest that FGFs, mainly produced by the 
perichondrium, act in a paracrine manner on FGFRs expressed on growth plate 
chondrocytes during postnatal life. Whereas FGFR1 and 3, which are negative 
regulators of chondrocytes, were expressed at higher levels in the hypertrophic zone; 
FGFR2 and 4, which are putative positive chondrocyte regulators, were expressed at 
earlier stages of differentiation, mainly in the resting zone (Lazarus, Hegde et al. 2007). 
Altogether, these findings point to the importance of FGF signaling in the control of 
post-natal growth.  Interestingly, temporal expression pattern showed down-regulation 
of FGFR2 and 4 in proliferative zone, and up-regulation of FGF 1, 7, 18 and 22 in 
perichondrium, suggesting that FGF signaling might play a role in the regulation of 
growth plate senescence and deceleration of longitudinal growth (Lazarus, Hegde et al. 
2007). 
1.4.2.6 WNTs (Wingless-type MMTV integration site family) 
The importance of Wnt signaling in skeletal development has been widely explored by 
several in vivo and in vitro studies (Macsai, Foster et al. 2008). At least 19 Wnts 
comprise a complex family of secreted cysteine-rich glycoproteins that interact with 
several receptors called Frizzled (Fzd) as well as co-receptors (Lrp5 and Lrp6). These 
Wnts are regulated by many antagonists, e.g. Secreted frizzled-related proteins (Sfrps) 
to finally activate different signaling pathways, including the canonical β-Catenin 
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pathway, and the non-canonicals calcium-releasing and JNK/planner cell polarity 
pathways. A key member of the canonical pathway, β-Catenin is an intracellular 
molecule involved in cell adhesion, which in the absence of Wnt signal is 
phosporylated and degraded, thus inhibiting gene transcription. Otherwise, activation of 
Wnt stabilizes β-Catenin, which then accumulates in the cytoplasm, migrates to the 
nucleus, heterodimerize with TCF/LEF transcription factors and ultimately mediates 
transcription of Wnt target genes.  
During bone formation, Wnt signaling inhibits chondrogenesis and enhances direct 
ossification, as seen by overexpression of Wnt14 and subsequent activation of the 
canonical β-Catenin pathway (Guo, Day et al. 2004; Day, Guo et al. 2005). Conversely, 
conditional inactivation of β-Catenin in undifferentiated mesenchymal cells using 
different mice models (Dermo1-Cre and Prx1-Cre) result in ectopic chondrocyte 
formation at the expenses of osteoblast differentiation (Hill, Spater et al. 2005; Hu, 
Hilton et al. 2005). Interestingly, Wnt signaling is also required during later 
chondrogenesis. Conditional knockout of β-Catenin in chondrocytes under the control 
of a type II collagen promoter (Co2a1-Cre) results in mice with short limbs, ectopic 
cartilage formation, but normal intramembranous ossification (Day, Guo et al. 2005). 
The generation of Col2a1-ICAT transgenic mice and therefore, decreased in β-Catenin 
signaling, resulted in viable mice with normal size at birth followed by progressive 
growth retardion (Chen, Zhu et al. 2008). Col2a1-ICAT transgenic mice showed 
reduced chondrocyte proliferation and differentiation, and an increase in chondrocyte 
apoptosis, leading to decreased widths of the proliferating and hypertrophic zones, 
delayed formation of the secondary ossification center, and reduced skeletal growth. 
These findings show that Wnt/ β-Catenin canonical pathway is essential throughout all 
stages of bone formation. 
During intramembranous ossification, Wnt signaling in the condensation is high, 
inhibits chondrocyte differentiation and also promotes osteoblast differentiation. 
During endochondral ossification, however, Wnt signaling in the condensation is kept 
low meaning that only chondrocytes can differentiate. Later, Wnt signaling is again up-
regulated in the periphery of cartilage, such that osteoblasts will differentiate, in order 
for the normal endochondral ossification to occur. One of the suggested mechanisms to 
control Wnt signaling in chondrogenesis is its inhibition by SOX9. Infection of 
mesenchymal progenitors in micromass culture with SOX9 or Wnt14 using adenovirus 
result in increased cartilage nodule formation at the outer rim of micromass culture 
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infected with SOX9 only; whereas Wnt14 inhibits cartilage nodule formation. 
Interestingly, co-infection with Sox-9 rescued cartilage nodule formation inhibited by 
Wnt14 to a large extent (Topol, Chen et al. 2009). Additional experiments in the same 
study show that SOX9 enhance β-catenin phosphorylation and its subsequent 
degradation, and thus inhibit Wnt signaling (Topol, Chen et al. 2009). In another 
interesting study, Wnt signaling has been implicated as downstream component of Ihh 
signaling, a master regulator of chondrocytes differentiation (Day and Yang 2008). 
Study in double mutant mice using COL2A1-Cre model with floxed alleles for Ptch1 
and β-catenin, hedgehog (Hh) signaling is cell autonomously activated, whereas β-
catenin is cell autonomously inactivated in developing long bones. Hedgehog (Hh) 
signaling was increased in the entire skeletal, especially in the perichondrium and 
articular cartilage, as well as PTHrP expression in the articular cartilage of these mutant 
mice (Mak, Chen et al. 2006). In the same study, bone formation was blocked in the 
perichondrium of the double mutant Ptch1; β-catenin mice, as in β-catenin single 
mutant mice, although Hh signaling was up-regulated (Mak, Chen et al. 2006). 
Altogether, these findings suggest that Wnt/β-catenin signaling is not required for Hh 
signaling itself, and acts downstream of Hh signaling in promoting bone formation.  
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2 AIMS OF THE THESIS 
The main goal of this thesis is to identify and explore new genes and intrinsic 
molecular mechanisms that are important for the spatial and temporal regulation of 
proliferation and differentiation of growth plate chondrocytes. We therefore aimed to: 
1. Identify gene expression changes that occur during the sequential differentiation 
of growth plate chondrocytes between distinct zones, as well as during growth 
plate senescence (Paper I); 
2. Study genes and pathways identified in previous study in order to explore their 
importance for temporal and spatial control of chondrocyte differentiation and 
proliferation within the growth plate (Papers II, III); 
3. Verify the intrinsic regulation of growth plate senescence by combining 
growth-inhibiting conditions and the study of structural, functional and gene 
expression changes within postnatal growth plate cartilage (Paper IV); 
4. Develop an in vitro model for growth plate chondrogenesis that allow for 
transient transfection of primary growth plate chondrocytes (Paper V). 
5. Identify developmentally regulated microRNAs and explore their role in growth 
plate chondrogenesis and senescence (Paper V);  
  
30 
3 ANIMAL & METHODS 
 
The following methods were used and will be briefly discussed. For specific 
procedures, please consult the individual papers: 
o Animal Model (Paper I-V) 
o Microdissection of the growth plate (Papers I- V) 
o Microarray analysis (Papers I and V) 
o Real-time qRT-PCR (Papers I-V) 
o In Situ hybridization of postnatal growth plate (Paper I) 
o Culture of Primary Chondrocytes (Paper V) 
o Transient Transfection (Paper V) 
o Transfection Efficiency Assessment (Paper V) 
o Proliferation assay - BrdU labeling followed by detection using ELISA 
(photometry) assay (Paper V) 
o Apoptosis analysis by using an ELISA-based method (photometry) assay 
(Paper V) 
 
3.1 ANIMAL MODELS 
We have mainly used rodents in the studies included in this thesis.  Sprague Dawley 
rats (Paper I, III and IV) and C57BL/6 mice (Paper II and V) were sacrificed to get 
their proximal tibial growth plate cartilage. In paper IV, we have used other two 
models with growth-inhibiting conditions. All studies were approved by local ethic 
committees.  
1. Normal and castrated rodents: Sprague Dawley rats (Paper I, III and IV) and 
C57BL/6 mice (Paper II and V) were sacrificed at 1-week-old to get epiphyseal 
proximal tibia for subsequent manual microdissection of individual zones of the 
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growth plate. For later time points, to avoid the interference of sex steroids, the 
animals were castrated before pubertal development starts (van Buul and Van den 
Brande 1978; Hunziker and Schenk 1989).  
2. Hypothyroidism induced rats (Paper IV): Growth of Sprague Dawley rats were 
inhibited in newborn male pups by introducing propylthiouracil (PTU) into 
drinking water of the mother from birth of the pups until 5-weeks-old of age, when 
we discontinued the treatment and allowed the hypothyroid rats to recover. The 
PTU treated pups were not weaned during treatment due to the fact that they are 
not mature enough to support their own nutritional needs during hypothyroidism 
state. The pups from lactating mothers not receiving PTU were used as controls 
and weaned at the normal age of 3-weeks-old. In addition, to avoid the interference 
of sex steroids in growth development, puberty was delayed by depot leuprolide 
acetate injections every 3 weeks. Depot leuprolide acetate is a long-acting 
gonadotropin-releasing hormone agonist that down-regulates gonadotropin 
secretion and thus gonadal steroid production (Ogawa, Okada et al. 1989). 
3. Tryptophan deficient (Trp-) rats (Paper IV): Sprague Dawley rat growth was 
inhibited by providing a Trp- diet to the lactating mother from birth of the pups 
until they reached 4-weeks of age. Then, treatment was suspended and the animals 
were allowed to recover. Male pups of not-treated mothers were used as a control.  
 
3.2 MICRODISSECTION OF GROWTH PLATE (PAPERS I-V) 
Manual microdissection of growth plate is a reliable and accurate technique that 
allows the study of individual growth plates of single animals (Nilsson, Parker et al. 
2007). Briefly, cartilaginous growth plates of Sprague-Dawley rats or C57BL/6 mice 
were excised from proximal tibia. To dissect distinct zones of growth plate, 7-days-
old animals were used. At this age, the growth plate is relatively tall and dissection of 
individual zones based on histological characteristics is more accurate and give 
enough amount of material to extract tRNA for the study of individual zones from a 
single animal. Frozen longitudinal sections (40-60 µm) of proximal tibial epiphyses 
were mounted on Superfrost Plus slides (Fisher Scientific, Chicago, IL, USA). Pre-
treatment of the slides with fixation and eosin staining was performed. Using an 
inverted microscope, razor blades, and hypodermic needles, growth plate sections, 
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under a xylene droplet, were separated based on histological hallmarks into distinct 
zones (Fig. 5).  
 
Fig. 5. Growth plate microdissection. Representative photomicrograph of microdissected proximal 
tibial growth plate from 1-week-old rat. The 60µm-thick longitudinal frozen sections were cut into 
resting zone, proliferative zone, prehypertrophic region and hypertrophic zone. In the section 
depicted, cuts were made, but the cartilage was left in place on the microscope slide. 
 
In order to minimize cross-contamination between zones, the uppermost part of one 
and the lowest part of next zone was discarded. Metaphyseal bone can be collected 
from a region of trabecular bone beginning approximately 100 µm distal to the 
hypertrophic zone.  For each zone, tissue dissected from both proximal tibias of one 
animal (18–25 sections) was pooled prior to RNA isolation. 50-200 ng of total RNA 
was extracted from growth plate of single animals, and then used for microarray or 
real-time PCR analysis (Paper I and V). 
 
3.3 MICROARRAY ANALYSIS (PAPERS I, V) 
Microarray is a high-throughput technique that allows the expression quantification of 
thousands of genes simultaneously. This thesis included two papers (Papers I and V) 
that use microarray analysis, which pursue the concept of finding predictive gene 
groups and signaling pathways from microarray data, which will generate likely 
hypothesis for the regulation of proliferation and differentiation of chondrocytes 
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within growth plate. This concept is motivated from the biological assumption that a 
few gene expression signatures are most accurate for phenotype discrimination. 
Furthermore, paper V also presents some innovative ideas resulting from the profiling 
of miRNAs and predicted target genes important for temporal regulation of 
chondrogenesis.  
3.3.1 mRNA Expression Microarray   
Expression quantification of thousands of genes is performed simultaneously by 
measuring the hybridization from the tissue of interest (e.g. growth plate and 
metaphyseal bone) to probes placed on a small glass slide. We used samples from 
single animals from the same litter, which minimize the variation of biological 
components and facilitate the interpretation of the results.  
For gene expression analysis (Paper I), we have used Affymetrix platform and the 
GeneChip 3´ In Vitro Transcription (IVT) Expression. Reverse transcription-IVT 
(RT-IVT) process is considered the gold standard for target preparation for gene 
expression analysis (Shi, Reid et al. 2006). The GeneChip arrays have a system where 
Oligonucleotides probes complementary to each corresponding sequence are 
synthesized in situ on the arrays. Poly-A controls (lys, phe, thr and dap) monitor the 
target labeling process from start to end, as sensitivity indicators of the entire target 
labeling process. The entire process is based upon linear RNA amplification and 
employs T7 in vitro transcription technology. For visualization of the GeneChip® 3’ 
IVT Express Protocol process, see figure 6.  
Briefly, total RNA (50-100ng) undergoes reverse transcription to synthesize first-
strand cDNA, which is primed with T7 oligo(dT) primer to synthesize cDNA 
containing a T7 promoter sequence.  This cDNA is then converted into a double-
stranded DNA template for transcription. The reaction employs DNA polymerase and 
RNase H to simultaneously degrade the RNA and synthesize second strand cDNA. In 
vitro transcription synthesizes cRNA with IVT labeling and incorporates a biotin-
conjugated nucleotide. In the amplification step, Master Mix generates multiple 
copies of biotin-modified cRNA from the double stranded cDNA templates. The 
cRNA is then purified to remove unincorporated NTPs, salts, enzymes, and inorganic 
phosphate to improve the stability of the biotin-modified cRNA. 
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Fig. 6. Overview of the GeneChip 3’ OVT Express Kit Labeling Assay 
Fragmentation of the biotin-labeled cRNA prepares the sample for hybridization onto 
GeneChip 3’ IVT expression arrays. After hybridization, the arrays are washed and 
stained using a Fluidics Station FS-450 (Affymetrix) following the EukGE-WS2v5 
protocol. The distribution of fluorescent material on the processed array is determined 
using the Affymetrix 3000 GeneArray laser Scanner with the 7G upgrade. Image 
inspection is performed manually immediately following each scan. All array 
scanning and data processing on the Affymetrix system is then performed with 
GeneChip Operating System (GCOS) software.   
3.3.2 miRNA Expression Microarray  
For miRNA microarray (Paper V), we used Agilent platform (Santa Clara, CA), which 
contain 20 probes targeting each of 567 mouse and 10 viral miRNAs from the Sanger 
database v10.1 (miRBase/ TargetScan, 2010). Labeling and hybridization of total RNA 
samples were performed according to the manufacturer's protocol. 100 ng total RNA 
was used as input into the labeling reaction, and the entire reaction was hybridized to 
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the array for 20 hours at 55°C. In combination with the miRNA microarray probe 
design, Cyanine 3-Cytidine bisphosphate (pCp) reagent selectively labels and 
hybridizes mature miRNAs. Use of these reagents ensures consistent results. Slides 
were scanned by using the Agilent DNA Microarray Scanner (Agilent), and results 
were extracted using Agilent Feature Extraction software (v10.5.1).  
3.3.3  Microarray Data Analysis  
Data analysis of microarray data is simplified by the use of bioinformatics tools, class 
prediction tools and higher stringency to select true effect observed by the technique. In 
the first paper, statistical and bioinformatic analysis of gene expression microarray 
data were performed by Partek Genomics Suite™ 6.3 (Partek Inc., St. Louis, MO). 
Probe-level data were pre-processed, including background correction, normalization, 
and summarization, using robust multi-array average (RMA) analysis (Bolstad, 
Irizarry et al. 2003; Irizarry, Hobbs et al. 2003). ANOVA analysis was performed for 
spatial and temporal comparisons on log-transformed data using Partek Pro software 
(Partek Inc.). In paper V, normalization and data analysis was performed by using 
GeneSpring software (GX11, Agilent, Santa Clara, CA). 
In order to identify functional pathways implicated in the spatial and temporal 
regulation of growth plate chondrocytes, Ingenuity Pathways Analysis Software 7.0 
(Ingenuity Systems Inc., Redwood City, CA) was used. Furthermore, validation of 
microarray findings was performed by real-time quantitative PCR (paper I and V) and 
in situ hybridization (paper I). 
3.4 REAL-TIME qPCR (PAPERS I-V) 
Real-time qPCR is a highly sensitive and specific method for detection of gene 
expression by logarithmic amplification (PCR) and simultaneous quantification of 
specific cDNA sequences, which reflects the concentration of specific transcripts in the 
sample analyzed. In this thesis, we have used real-time RT-PCR to study the expression 
of specific genes (Papers II, III, IV) and miRNAs (Paper V) found to be important in 
the regulation of growth plate chondrocytes based on previous microarray findings. 
Briefly, by using a DNA polymerase enzyme that is tolerant to elevated temperatures, 
mRNA is copied to cDNA by reverse transcriptase and random hexamer oligoprimers. 
The cDNA is more stable than RNA and furthermore allows amplification by DNA 
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polymerase. Interestingly, the cDNA mirror the RNA content of the tissue analyzed, 
and therefore the converted mRNA contains merely exons, since the introns are spliced 
away in mature mRNAs.  
The basic idea of the technique is that the more abundant a particular mRNA is in the 
sample, and thus cDNA after reverse transcription, the earlier it will reach a threshold 
during repeated cycles of amplification. In contrast to semi-quantitative PCR that only 
provide information of amplification product amount at the end of the reaction, q-PCR 
assess the amount of synthesized amplification product in every amplification cycle and 
relative abundances of each transcript can be assessed during the logarithmic phase of 
amplification. The data collection is fluorescence based. Two commonly used 
chemistries for detection are TaqMan probe and SYBR green. SYBR green directly 
binds to double-stranded DNA (amplification products) and emits light. As SYBR 
green dye binds to any double-stranded DNA molecular, including primer-dimers and 
other non-specific reaction products, it may lead to an overestimate of the PCR product.  
On the other hand, TaqMan probe is more precise to detect gene expression. Briefly, 
TaqMan probe are oligonucleotides with a high energy reporter dye on the 5’ end and 
low energy quencher dye at the 3’ end. Before reaction, two dyes sit together by which 
the emission of reporter dye is suppressed by the quencher dye. During PCR when 
DNA replication reaches to the TaqMan probes bonded on template, the 5’-nuclease of 
Taq DNA polymerase enzyme cleaves the probe. The release of reporter from quencher 
increases fluorescent emission of reporter. The signal increases in direct proportion to 
the amount of PCR product in the reaction.  
Since not all tissues samples have the exact same rate of overall gene transcription and 
the same amount of cell contents, normalization against a constantly expressed 
housekeeping gene is commonly performed and mRNA relative quantification is 
analyzed. In our studies, we quantified the relative expression from all samples against 
the housekeeping gene 18S ribosomal RNA (18S rRNA) for gene expression studies; 
and the small nucleotide202 (sno202) for miRNA study, which have previously been 
shown to be constantly expressed in most tissues (Wong L 2007), confirmed in growth 
plate samples . Real-time qPCR was performed as it is described in each paper.  
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3.5 IN SITU HYBIDRIZATION OF POSTNATAL GROWTH PLATE 
(PAPER I) 
In situ hybridization was performed using frozen sections of growth plate cartilage of 
1-week-old rats hybridized to 35S-labeled riboprobes as described by Zhou et al 
(Zhou, Chin et al. 1991). Briefly, cDNA from growth plate was PCR-amplified by 
two sequential amplifications using specific primers that contain either a T7 promoter 
or an SP6 promoter (Divjak, Glare et al. 2002). Next, single stranded 35S-labeled 
riboprobes for in situ hybridization were produced by in vitro transcription using T7 
or SP6 RNA polymerase α-35S labeled nucleotides. T7 polymerase was used for sense 
probes and SP6 polymerase for antisense probes. Riboprobes were purified by Micro 
Bio-Spin Columns P-30-Tris-RNase free. 35S incorporation was assessed by 
comparing radioactivity before and after the column purification, by liquid 
scintillation counting. Hybridization of pre-treated frozen sections to 35S-labeled 
riboprobes was performed as described by Zhou et al (Zhou, Chin et al. 1991). The 
sections were then counterstained with hematoxylin and eosin. Silver grains were 
visualized by scanning the slides with ScanScope CS digital scanner (Aperio 
Technologies, Inc.) under bright field microscopy. The corresponding sense riboprobe 
was used as a negative control for each antisense probe. 
 
3.6 QUANTITATIVE HISTOLOGY (PAPERS IV) 
Masson Trichrome-stained sections of paraffin embedded samples of growth plate 
from proximal tibia were used for quantitative histology using a ScanScope CS digital 
scanner (Aperio Technologies, Inc. Vista, CA). Measurements were taken as 
previously described (Marino, Hegde et al. 2008). Height of individual zones and 
whole growth plate, columns density and the height of the terminal hypertrophic 
chondrocyte lacuna (the intact lacuna closest to the metaphyseal bone) were assessed 
by a blinded observer to the age and treatment group. Overall growth plate height was 
measured from the margin of the metaphyseal bone to the margin of the epiphyseal 
bone; resting zone height, measured from the edge of the margin of the epiphyseal bone 
to the first cell of a proliferative column; hypertrophic zone height, measured from the 
margin of the methaphyseal bone to the last cell bigger or equal to 10 μm; proliferative 
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zone height, measured from the first cell minor to 10 μm to the first resting 
chondrocytes; the number of resting zone chondrocytes, assessed as the number of cells 
per 200 μm growth plate width (measured parallel to the epiphyseal margin); column 
density, assessed as the number of hypertrophic columns per 500 μm growth plate 
(measured parallel to the metaphyseal margin); and the height of the terminal 
hypertrophic chondrocyte lacuna (the intact lacuna closest to the metaphyseal bone). 
Heights were measured parallel to the chondrocyte columns in 3 areas of each growth 
plate section and averaged.  Column density was calculated in 2 areas per growth plate 
section. The number of proliferative and hypertrophic cells was counted in 3-4 intact 
columns per growth plate. Hypertrophic chondrocytes were operationally defined by a 
height ≥10 μm. The terminal hypertrophic cell height was measured in 8-10 different 
columns per growth plate section. For each animal, 3 different growth plate sections 
were analyzed and then all measurements from that animal were averaged. 4-5 animals 
were studied per treatment and time point. All histological measurements were 
performed in the central two-thirds of the growth plate sections to avoiding regions 
close to the perichondrium  
 
3.7 PRIMARY CULTURE OF GROWTH PLATE 
CHONDROCYTES (PAPER V) 
The use of primary cultures of growth plate chondrocytes offered important 
advantages for our studies. We needed an in vitro model that allowed for efficient 
transfection of cells and with relevance to in vivo growth plate chondrogenesis. 
Therefore, we opted for primary chondrocytes cultures.. Primary chondrocytes retain, 
at least partly, their chondrogenic phenotype and signaling pathways involved in its 
regulation, thereby providing information of relevance to the chondrogenesis, and 
experimental conditions can be easily controlled. In addition, we have used 
chondrocytes mainly from the resting zone, aiming to study proliferation and 
differentiation of young chondrocytes, without the confusing factor of already 
differentiated hypertrophic chondrocytes. In order to obtain  resting zone, we used 
young mice (3-5 days-old), since their growth plate is taller, the secondary 
ossification center is absent, and chondrocytes from the epiphyseal and resting zone 
represent relatively large portion of the entire growth plate. To increase the number of 
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cells obtained, we dissect cartilage growth plate from proximal tibia, distal femur and 
distal tibia from each animal. Briefly, growth plates were dissected aseptically and 
digested in 0.3% collagenase type IA. The released cells were resuspended in 
Dulbecco's modified eagle medium/Hams F12, 10% fetal calf serum (FCS), 1% 
penicillin (100 U/ml)/ streptomycin (100 μg/ml), sodium pyruvate (100 μg/ml) and 50 
μg/ml ascorbic acid, and then plated at a density of 105 cells/cm2 in 96-well-plates.  
 
3.8 TRANSIENT TRANSFECTION OF miRNAs (PAPER V) 
3.8.1 Transfection of Primary Chondrocytes 
Transfection is the process of introducing genetic content into a cell by means other 
than viral transduction, such as via electroporation or liposome-mediated fusion. The 
technique has been of exceptional value for functional studies in cell lines or primary 
cells, in which the researcher can modify the expression of a particular gene or 
miRNA through inhibition or overexpression, and observe possible phenotypic 
effects on the cell, such as proliferation, cell death and pure morphological changes. 
For most applications of transfection, it is sufficient if the transfected gene is only 
transiently expressed. Since miRNA introduced in the transfection process only needs 
to reach the cytoplasm and their effects on cell phenotype may be analyzed after 24 
hours, this type of transfection is adequate for our study. We performed transient 
transfection of precursor (gain-of-function) or inhibitor miRNAs (knock-down) into 
primary murine chondrocytes by using Lipofectamine 2000, a lipid-based solution 
that transfers the construct miRNA into the cells by merging with the cell membrane. 
Briefly, primary chondrocytes were transfected by incubation of cells in 100nM 
precursors (pre-miR), inhibitors (anti-miR), or negative control (nonspecific) 
oligonucleotides miRNAs by using Lipofectamine 2000 (Invitrogen) in serum-free 
media (Opti-MEM I). This liposome mediated transfection study is highly efficient, 
with a transfection rate between 80 and 90%, and fairly non-toxic to the primary 
murine chondrocytes.  
3.8.2  Transfection Efficiency Assessment 
Fluorescence-Activated Cell Sorting (FACS) has a variety of applications, and was 
used in paper V for assessment of labeled-miRNAs transfected cells. FACS is a form 
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of flow cytometry, where cells pass through a laser in a hydrodynamically focused jet 
of fluid. As the cells pass through the light beam, they scatter the light depending on 
the physical and chemical characteristics of the cell. These characteristics are 
recorded for each cell by detectors and provide a range of information about the 
observed cells. Cells marked with fluorescent labels emit light when passing through 
the beam, and can be sorted into different containers based on the presence or absence 
of fluorescent signals. Sorting is done though breaking the hydrodynamically focused 
fluid jet containing the cells into droplets immediately following the measuring 
station. A charge is placed on each droplet depending on its fluorescent status, and 
differentially charged droplets are deflected in an electrostatic field, thereby sorting 
them into different fractions. 
Transfection efficiency of Cy-3-labeled negative-controls for pre-miR and anti-miR 
miRNAs (Ambion) was found to be between 80-90% in repeated experiments. After 
one wash with PBS, cells were trypsinized, pelleted and resuspended in PBS 
containing 1% FCS. Cell cytometry was performed using a FACScan cell analyzer. 
WinMD12.8 was used for analyses of FACS data.  
Furthermore, effective delivery and activity of positive control anti-miR and pre-miR 
was detected by real-time PCR quantification of their respective targets.  Endogenous 
Let-7 miRNA negatively regulates HMGA2, a ubiquitously expressed nonhistone 
chromatin protein (Lee and Dutta 2007). Pre-miR-1 miRNA precursor effectively 
down regulates the expression of Twf1 (twinfilin, actin-binding protein 1) at the 
mRNA level (Lim, Lau et al. 2005). In our cells, transfection with anti-let-7-miR 
increased HMGA2 mRNA abundance by 100%, while transfection with  pre-miR-1 
down-regulated Twf1 gene expression by 70%. Altogether, the data confirm that the 
developed protocol for transfection of primary growth plate chondrocytes results in 
efficient transfection and that the model is adequate and may be used to explore the 
functional role of selected miRNAs in growth plate chondrogenesis.  
 
3.9 PROLIFERATION ASSAY (PAPER V)  
In paper V, incorporation of bromodeoxyuridine (BrdU, 10uM) into newly 
synthesized DNA of proliferating chondrocytes was measured by ELISA 
(photometry) to quantify cell proliferation. Bromodeoxyuridine (BrdU) is an analogue 
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of thymidine and competes with thymidine for incorporation into the forming DNA.  
Differences in BrdU incorporation by proliferating chondrocytes is reliably recorded 
by a microplate ELISA reader and comparable between different experiments.  
 
3.10  CELL DEATH ELISA (PAPER V) 
Cell death may occur by two mechanisms: apoptosis and necrosis, and both types 
have their own specific and distinct morphological and biochemical characteristics. 
During chondrogenesis, apoptosis is the main mechanism of cell death, especially in 
the hypertrophic zone. In our study, for detection of apoptosis in cultured transfected 
chondrocytes, we used Cell Death ELISA plus (Roche® Applied Science, 
Indianapolis, IN), which detects cytoplasmic histone-associated DNA fragments 
(mono- and –oligonucleassomes) by photometric enzyme immunoassay. The assay 
detects nucleasomes (histone complexed DNA fragments) in the cytoplasm of treated 
cells with the use of monoclonal antibodies against histone and single-stranded DNA. 
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4 RESULTS AND DISCUSSION 
 
4.1 MARKERS FOR CHONDROCYTES DIFFERENTIATION 
AND GROWTH PLATE SENESCENCE (PAPER I)  
To obtain an overall, unbiased assessment of how gene expression is regulated as 
chondrocytes undergo spatially-associated differentiation and temporally-associated 
senescence, we used microdissection of postnatal rat growth plates into their constituent 
zones combined with microarray analysis. Here, we report the overall results of the 
microarray study, using bioinformatic approaches to identify functional pathways and 
explore large-scale patterns in gene expression that may regulate the processes of 
postnatal chondrogenesis, and therefore identify specific gene products that may be 
used as molecular markers for the spatial zones and for temporal development.  
In the transition from the resting to the proliferative zone, expression of 677 genes was 
upregulated and expression of 631 genes was downregulated (with P < 0.01 by 
ANOVA, Table1A). Functional pathways most implicated in this transition included: 
vitamin D receptor / retinoid x receptor (VDR/RXR) activation, platelet-derived growth 
factor (PDGF) signaling, BMP signaling, and notch signaling (all P < 0.05, Table1A).   
In addition, we detected biological functions most strongly implicated in this step of 
differentiation, such as: cellular development, cellular growth and proliferation, cell-to-
cell signaling and interaction (all P < 0.0001, Table1A), all of which are consistent with 
the known biological changes occurring in this transition. These differences in 
expression between zones represent the changes in expression that occur as 
chondrocytes differentiate from the resting to the proliferative and then to the 
hypertrophic state. BMPs have already been shown to play an important regulatory role 
in the growth plate (De Luca, Barnes et al. 2001; Pogue and Lyons 2006; Nilsson, 
Parker et al. 2007),  including a role in differentiation of mesenchymal cells into 
chondrocytes (Solomon, Berube et al. 2008), of proliferative chondrocytes into  
hypertrophic chondrocytes (Kobayashi, Lyons et al. 2005; Pogue and Lyons 2006; 
Solomon, Berube et al. 2008) and proliferation of resting zone chondrocytes (De Luca, 
Barnes et al. 2001).  PDGFs have been shown to stimulate proliferation of cultured 
growth plate chondrocytes (Hiraki, Inoue et al. 1988; Wroblewski and Edwall 1992; 
Bulman, Iannotti et al. 1995; Olney, Wang et al. 2004; Kobayashi, Lyons et al. 2005), 
but there is less information about their role in vivo.  Members of the notch family and 
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their receptors are expressed by hypertrophic chondrocytes (Hayes, Dowthwaite et al. 
2003), but little is known about their role in growth plate chondrocyte differentiation. 
Vitamin D receptor ablation in mice causes important growth plate abnormalities but 
this appears to be related to the resulting abnormal mineral homeostasis (Demay 2006), 
and at least some of the direct effects of vitamin D on the growth plate appear not to be 
mediated by the nuclear vitamin D receptor.  
 
Table 1. Bioinformatic analysis of the genes changing between zones,  from: A) resting zone to 
proliferative zone, and from: B) proliferative zone to hypertrophic zone in the growth plate cartilage of 1 
wk old rats using the computer program Ingenuity Pathway Analysis 7.1. 
 
Next, we identified that expression of 1717 genes was upregulated and expression of 
1625 genes was downregulated (with P < 0.01 by ANOVA, Table 1B) in the transition 
from the proliferative to the hypertrophic zone. Biological functions most strongly 
implicated in hypertrophic differentiation included: cellular growth and proliferation, 
cellular movement, cell death, cell cycle, and DNA replication, recombination, and 
repair (all P < 10-8, Table1B). Functional pathways that were implicated in this 
transition included: p53 signaling, cell cycle: G2/M regulation, cell cycle: G1/S 
regulation, ephrin receptor signaling, oncostatin M signaling, and BMP signaling (all P 
< 0.05, Table1B). P53 may play a role in apoptosis of growth plate chondrocytes [24]. 
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Ephrin receptors, which interact with membrane-bound ligands causing bidirectional 
signaling, have been implicated in bone remodeling [25] but not, to our knowledge, in 
growth plate biology previously. Similarly, Oncostatin M, a pleiotropic member of the 
interleukin-6 cytokine family[26], has not, to our knowledge, previously been 
implicated in growth plate biology. 
Changes associated with growth plate senescence were assessed by comparing gene 
expression in growth plate cartilage of 3-week-old versus 12-week-old rats.  With age, 
expression of 1221 genes was upregulated and expression of 1046 genes was 
downregulated (with P < 0.01 by ANOVA, Table2). Biological functions most strongly 
implicated in growth plate senescence included: small molecule biochemistry, cell 
death, cell morphology, cellular growth and proliferation, cellular function and 
maintenance (all P < 0.0001, Table2). Functional pathways that were implicated in 
growth plate senescence included: eisosanoid signaling, VDR/RXR activation, p38 
mitogen-activated protein kinase (MAPK) signaling, and Wnt/β-catenin signaling (all P 
< 0.05, Table2).  
 
 
Many of the detected pathways have previously been implicated in growth plate 
chondrocyte regulation (Vortkamp, Lee et al. 1996; Rosado, Schwartz et al. 2002; 
Table 2. Senescence (3-wk vs 
12-wk) of growth plate. 
Bioinformatic analysis of the 
genes changing in the 
proliferative zone from 3 wk to 
12 wk old rats using the 
computer program Ingenuity 
Pathway Analysis 7.1. 
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Agoston, Khan et al. 2007; Wang, Shao et al. 2007; Chen, Zhu et al. 2008)  generally, 
but not specifically in the programmed loss of function and other senescent changes 
that occur during postnatal life. Furthermore, comparison of gene expression changes 
during chondrocyte differentiation and senescence did not reveal a substantial 
overlap, thus suggesting that the mechanisms that block proliferation as chondrocytes 
hypertrophy is different from those that restrict proliferation with increasing age. 
In addition, we have identified potential markers that show greater than 10-fold 
specificity for each of these zones. Some, but not all, of these potential markers have 
known or suspected roles in chondrocyte biology. For the resting zones, the highest-
ranking marker was secreted frizzled-related sequence protein 5 (Sfrp5), which showed 
mRNA levels in the resting zone that was 15-fold higher than in proliferative zone and 
60-fold higher that in the hypertrophic zone (see Fig. 1). 
 
Fig. 7. Spatial Markers for Growth Plate Senescence. Changes in gene expression (mean ± SEM) 
of spatial markers across the tibial growth plate of 1-week-old rats. (A) The relative expression 
of mRNA in each zone was measured by expression microarray (Affymetrix Rat Genome Array 
230 2.0). (B) The relative expression of Sfrp5, Pcp4, Efemp1, Lrrc17, Pcdh17, and Prelp was 
verified using quantitative real-time PCR. RZ, resting zone; PZ, proliferative zone; HZ, 
hypertrophic zone.  
The highest-ranking marker identified for the proliferative zone was growth 
differentiation factor 10 (Gdf10), which is a member of the BMP family and which 
showed mRNA levels in the proliferative zone that were 16-fold higher than in the 
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resting zone and 110-fold higher than in the hypertrophic zone (Fig. 7). And, for the 
last, the hypertrophic zone, the two highest-ranking markers were tissue non-specific 
alkaline phosphatase (Alp1) and collagen X (Col10a1), two widely used markers for 
hypertrophic chondrocytes (Fig. 7). Other candidate markers for all zones are shown in 
Fig. 7B.  To further confirm our findings, the localization of several spatial markers in 
1-week-old growth plate was studied by in situ hybridization (Fig. 8). The identified 
mRNAs are likely to prove useful as markers for the resting and proliferative zones in 
studies using RNA-based methods, as we showed using in situ hybridization and real-
time qPCR. 
 
Fig. 8. mRNA expression of Sfrp5, Gdf10, and Prelp in growth plate cartilage of 1-week-old rats by 
in situ hybridization. The left hand panel in each row shows the proximal tibial at low 
magnification. The other panels show high magnification views of resting zone (RZ), proliferative 
zone (PZ), and hypertrophic zone (HZ) taken from within the rectangular area indicated in the 
corresponding left hand panels. 
 
In addition to spatial regulation, we identified multiple genes that showed large 
increases in expression with age and other genes that showed large decreases at either 
3-wks (youth markers) or 12-wks (aged markers) (Fig. 9). For the young growth 
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plate, the highest-ranking marker was insulin-like growth factor 2 (IGF2), which 
showed mRNA levels 82-fold higher at 3-wks than at 12-wks. For the old growth 
plate, the highest-ranking marker was Pycard (PYD and CARD domain containing), 
which showed mRNA levels increased 9-fold from 3-wks to 12-wks of age (Fig.  3). 
The expression level of these genes may be useful indicators of the maturational state 
and residual proliferative capacity of the growth plate chondrocytes, and therefore can 
be employed to study processes that delay (Marino, Hegde et al. 2008) or accelerate 
(Weise, De-Levi et al. 2001) growth plate senescence. Whether the proteins encoded 
by these mRNAs will prove useful as markers using immunohistochemistry or 
western blot analysis remains to be determined.  
 
 
 
 
Although bioinformatic analysis of expression microarray findings can identify 
important functional pathways involved in a physiological, pathological, or 
pharmacological process, this approach is neither completely sensitive nor specific. 
Therefore, the findings in the current study can only be considered as hypothesis 
generating. For some of the novel pathways implicated in growth plate senescence, 
Fig. 9. Temporal Markers 
for Growth Plate 
Senescence. Changes in 
gene expression 
(mean±SEM) of senescence 
markers in the proliferative 
zone of 3-, 6-, 9-, and 12-
week-old rats. Proliferative 
zones of the growth plate 
cartilage were 
microdissected. (A) The 
relative expression of 
mRNA at different ages was 
measured by expression 
microarray (Affymetrix Rat 
Genome Array 230 2.0). 
The data was background 
corrected and normalized 
using the MAS5 statistical 
algorithm. (B) The relative 
expression of Frzb, Fgl2, 
Matn1, Irx4, Syt8, and 
Tm4sf1 was verified using 
quantitative real-time PCR 
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such as Wnt signaling, and genes implicated in growth regulation (e.g. imprinted genes, 
data not shown); additional studies were performed to confirm the expression findings 
using independent methods and to investigate their functional role in postnatal 
chondrogenesis. 
 
4.2 ROLE OF WNTs IN POSTNATAL GROWTH PLATE (PAPER 
II) 
Wnt/β-catenin signaling was one of the most implicated pathways in the 
developmental program of growth plate senescence revealed in our microarray 
analysis (Paper I). Although the importance of Wnt signaling in chondrogenesis is 
well established, little is known about which specific Wnts are responsible for these 
effects. This gap in our understanding is particularly evident in the postnatal growth 
plate, since most previous work has focused on the embryonic skeleton. We therefore 
examined the expression profile of Wnt family members in distinct zone of growth 
plate and metaphyseal bone, by using microdissection followed by real-time qPCR, a 
quantitative method with greater sensitivity and specificity than previous techniques.  
Of the 19 known members of the Wnt family, only six, Wnts -2b, -4, -5a, -5b, -10b, 
and -11, were clearly detected both in whole growth plate and individual zones (Fig. 
10). Although ours is the first study to investigate extensively Wnt expression in the 
postnatal mammalian growth plate, some of these members of the Wnt family, Wnts -
4, -5a and -5b, had previously been implicated in embryonic mammalian cartilage, 
whereas Wnts -2b, -10b, and -11 had not been implicated in the regulation of the 
mammalian growth plate at any stage of development. Interestingly, of those six 
Wnts, three (Wnts -2b, -4, and -10b) signal through the canonical Wnt/β–catenin 
pathway and three (Wnts -5a, -5b, and -11) signal through the noncanonical, calcium 
pathway. 
In addition, all detected Wnts presented spatial expression remarkably similar (Fig. 
10). As the chondrocytes passed into the proliferative state and the prehypertrophic 
state, expression of these Wnts appeared to increase. As the cells underwent terminal 
differentiation to the hypertrophic state, Wnt expression tended to decline. This 
overall pattern of gene expression is broadly consistent with previous studies in the 
mouse embryo suggesting that Wnts that signal through both the canonical and 
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noncanonical pathways modulate chondrocyte hypertrophic differentiation. 
Specifically, Wnts -4, -5a, -5b, -10b, and -11, all showed relatively low expression in 
resting zone.  
 
 Fig. 10. Temporal Markers for Growth Plate Senescence. Relative mRNA expression of Wnt 
family members in growth plate zones from 1-week-old mice (n = 6). 
Among the Wnt family members that signal through β–catenin, Wnt-4 had the highest 
mRNA expression in the growth plate. The observed expression pattern is compatible 
with previous studies showing that Wnt-4 overexpression accelerates hypertrophy of 
chondrocytes (Hartmann and Tabin 2000).  However, mice null for Wnt-4 have been 
reported to have either no growth plate phenotype (Stark, Vainio et al. 1994) or a slight 
delay in chondrocyte maturation (Spater, Hill et al. 2006). Our data suggest that this 
mild phenotype, which contrasts with the more severe delayed hypertrophic 
differentiation and decreased chondrocyte proliferation of mice lacking β–catenin, may 
be attributable to redundancy between Wnt-4 and Wnt-10b, which also acts through the 
β–catenin pathway and shows a similar spatial expression pattern. Consistent with this 
hypothesized redundancy in growth plate, mice lacking Wnt-10b display decreased 
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trabecular bone but have not been reported to have abnormal endochondral bone 
formation at the growth plate (Bennett, Longo et al. 2005).  Wnt-2b, although 
expressed at low levels, may also contribute to redundancy. In our study, Wnt-2b, 
which is required for limb initiation in zebrafish and chick (Kawakami, Capdevila et al. 
2001; Ng, Kawakami et al. 2002), was a partial exception to the overall expression 
pattern, since it did not seem to decrease in the hypertrophic zone and was absent in 
resting and proliferative chondrocytes (Fig. 10). There is no study involving ablation or 
overexpression of Wnt-2b in growth plate to add insights about its role in growth plate 
regulation. We speculate if Wnt-2b may be important in the process of chondrocyte 
hypertrophy and terminal differentiation, but additional functional studies are required.  
Conversely, the noncanonical calcium pathway can antagonize the canonical Wnt/β–
catenin pathway by promoting the degradation of β–catenin (Topol, Jiang et al. 2003; 
Katoh 2005), and appears to have an important role in growth plate formation and 
function. Wnt-5a null mice display a severe skeletal phenotype with limb truncation. In 
growth plates, chondrocyte hypertrophy is delayed, suggesting that Wnt-5a promotes 
chondrocyte hypertrophy (Yamaguchi, Bradley et al. 1999; Yang, Topol et al. 2003)). 
Wnt-5b overexpression appears to have different effects, promoting proliferative zone 
formation and inhibiting cell cycle withdrawal and chondrocyte hypertrophy (Yang, 
Topol et al. 2003). The expression pattern detected in this study is consistent with the 
findings from mouse models, described above, suggesting that Wnts -5a and -5b may 
modulate production of proliferative zone chondrocytes and their conversion to 
hypertrophic chondrocytes. This expression pattern is also similar to, though perhaps 
not identical to, the expression pattern observed by in situ hybridization in the 
embryonic skeleton; Wnt-5a was observed in proliferative and prehypertrophic 
chondrocytes and Wnt-5b in the region between prehypertrophic and hypertrophic 
chondrocytes (Yang, Topol et al. 2003). Little is known about Wnt-11 function in the 
mammalian growth plate. Overexpression of Wnt-11 in the developing chick limb 
results in slightly truncated limbs and joint fusion but does not appear to delay 
chondrocyte differentiation (Church, Nohno et al. 2002). Our study, showing similar 
expression patterns for Wnts -5a, -5b, and -11, all of which signal through the calcium 
pathway, suggest that these three members of the Wnt family may have redundant, 
overlapping, or interacting roles in the growth plate.  Therefore, ablation of these genes 
in combinations may reveal a growth plate phenotype that is more severe and perhaps 
qualitatively different than occurs with ablation of any single one of these genes. 
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Interestingly, the similarity between the general pattern of Wnt expression and Ihh 
expression in the growth plates of 1-week-old mice suggests a possible interaction 
between both pathways. In embryonic mouse long bones, Wnt-9a ablation caused 
downregulation of Ihh expression and signalling (Spater, Hill et al. 2006). Whether 
Wnts, either those signalling through the canonical pathway or those signalling through 
the calcium pathway, interact with Ihh in the postnatal growth plate is unknown and 
speculative. 
Some of the Wnt genes that we found to be expressed in the postnatal growth plate 
have also been implicated in other models of postnatal chondrogenesis. Human dermal 
fibroblasts cultured in the presence of chondroinductive demineralized bone powder 
show increased expression of Wnts -2b, -5b, and -10b (Yates 2004), whereas Wnts -4, -
5a and -5b are up-regulated during bone repair in vivo (Hadjiargyrou, Lombardo et al. 
2002; Zhong, Gersch et al. 2006).  
To rule out the role of the identified Wnts in growth plate senescence, we hypothesized 
that change in Wnt gene expression might explain the functional changes in growth 
plate observed with age. We therefore studied Wnt expression in the mouse growth 
plate at 4 weeks, an age by which longitudinal bone growth has slowed markedly, 
approximately two-fold, in the mouse (van & Van den 1978).  Contrary to our 
hypothesis, we found that all Wnts that had been readily detected in the growth plates 
of 1-week-old mice were still expressed in growth plate cartilage of 4-week-old mice, 
at similar levels (Fig. 10). Because the growth plate height is diminished at this age in 
mice, we were only able to microdissect the growth plates in two regions, the 
resting/proliferative and prehypertrophic/ hypertrophic regions. As a result, our 
comparisons to 1-week-old mice were less precise. However, we can conclude that 
expression of the Wnts that we detected in growth plate at 1 week persists and remains 
at similar at levels at 6 weeks, but we cannot exclude modest changes in gene 
expression of Wnts with age, since the expression analysis from two distinct zones 
combined may hide or compensate subtle but significant changes expected with age 
(Fig. 11). In addition, change in expression of Wnt family may include other genes 
involved in its signaling, such as receptors (e.g. Frizzled), co-receptors (Lrp5, Lrp6) 
and Wnt-antagonists (e.g. Sfrp).  
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4.3 GROWTH-REGULATED NETWORK OF IMPRINTED GENES 
IN THE POST-NATAL GROWTH PLATE (PAPER III) 
In this study, we present data suggesting that a growth regulating imprinted gene 
network (Cdkn1c, Grb10, Gtl2, Mest, Dlk1, Peg3, Ndn, Slc38a4, H19, and 
Plagl1/Zac1) previously implicated in the control of embryonic (Varrault, Gueydan et 
al. 2006) and postnatal growth deceleration of multiple tissues ((Lui, Finkielstain et al. 
2008) might show a similar coordinate down-regulation in rat metaphyseal bone, but a 
more gene-specific pattern of expression in proliferative chondrocytes of rat growth 
plate cartilage.  
Similar to previous findings in kidney, lung and liver, expression of all studied genes, 
except Gtl2, declined significantly with age in metaphyseal bone (Fig. 12A).  In 
contrast, in growth plate, we found that expression of growth-promoting genes, Mest, 
Dlk1, and Gtl2 (all P < 0.001), decreased with age in PZ, whereas growth-inhibitory 
genes, Cdkn1c and Grb10 (P < 0.001; P < 0.05 respectively) increased with age (Fig. 
Fig. 11. Temporal Expression of 
Wnts in Growth Plate. Relative 
mRNA expression of Wnt family 
members in growth plates of 1-
week and 4-week-old mice (n = 6). 
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12B). Those findings are thus consistent with the hypothesis that this network of 
imprinted genes contributes to the developmental decline in the rate of longitudinal 
bone growth that occurs during postnatal development.  
 
Fig. 12. Temporal mRNA expression of imprinted gene network. A) In metaphyseal bone (MB); and B) 
In growth plate proliferative zone (PZ), from 1-, 3-, and 9-week-old rats (n = 5, all ages). Real-time qRT-
PCR normalized to 18S rRNA, and, for convenience, multiplied by 106.  * P < 0.05; ** P < 0.01; *** P < 
0.001. 
In order to explore the role of this network of imprinted genes in the regulation of 
growth plate chondrocyte differentiation, we also characterized its expression in 
individual zones of the growth plate (Fig. 13).  To our knowledge, this is the first report 
characterizing the expression patterns of these genes, except Igf2, in growth plate 
cartilage. We have previously shown that Igf2 mRNA expression decrease from RZ to 
PZ in growth plate cartilage of 1-week-old rats (Parker, Hegde et al. 2007). Expression 
of other six genes (Mest, Dlk1, Peg3, Grb10, Gtl2 and H19) in the network thus 
decreases as chondrocytes differentiate from RZ to HZ chondrocytes. Four of these 
genes (Mest, Dlk1, Peg3, and Gtl2) promote growth, and their expression pattern 
suggests that they promote proliferation in the RZ and/or PZ. Interestingly, all genes 
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that were found to decrease with age (Mest, Dlk1, Gtl2, H19 and Igf2) also decreased 
during chondrocyte differentiation. These findings may suggest that the network not 
only contribute to the decline in proliferation that occurs during growth plate 
senescence, but possibly also to the inhibition of proliferation that occurs during 
hypertrophic differentiation. In contrast, comparisons of global gene expression 
changes during growth plate senescence and growth plate chondrocyte differentiation 
do not show substantial overlap (data not shown). Therefore, on a transcriptsome level, 
growth plate senescence bare little similarity with hypertrophic differentiation, but in 
regard to the studied network of imprinted genes, the process of growth plate 
senescence show transcriptional similarities to chondrocyte differentiation. 
 
4.4 GROWTH PLATE SENESCENCE IS A FUNCTION OF 
GROWTH (PAPER IV) 
We have shown in the first paper of this thesis that several genes change their 
expression with postnatal age in the rat PZ, based on microarray data analysis, 
Fig. 13. Spatial mRNA expression 
of imprinted genes in resting (RZ), 
proliferative (PZ), and 
hypertrophic (HZ) zones of growth 
plate and metaphyseal bone (MB) 
from 1-week-old rats (n = 5). 
Quantitative real-time RT-PCR was 
performed on samples from 
individual animals, normalized to 
18S rRNA, and, for convenience, 
multiplied by 106. 
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suggesting that there is also a developmental program withing growth plate cartilage 
in addition to the specific changes observed at the functional and structural level.   
This developmental program has been termed “growth plate senescence” and takes 
place as longitudinal bone growth decline with age (Nilsson and Baron 2004). Delay 
in growth plate senescence after transient hypothyroidism in rats (Marino, Hegde et 
al. 2008) suggests that growth plate senescence is a function of growth rather than 
age. We reasoned that if this hypothesis is true, then growth plate senescence would 
be slowed down by any growth inhibiting condition, not only by hypothyroidism. To 
test this hypothesis, we used another model of transient growth inhibition, providing 
newborn rats a tryptophan deficient diet (Trp-) during the first four postnatal weeks.  
We found that during recover of the induced growth inhibition, molecular (Fig. 14A), 
functional (Fig. 14B) and structural markers (Fig. 14C) of growth plate senescence 
were delayed by prior Trp- deficiency indicating that the developmental program of 
senescence had occurred more slowly during the period of growth inhibition. Tibial 
growth rate, which is a functional marker of growth plate senescence, declined in 
control animals and was delayed in Trp- rats compared to controls (P<0.001, Fig. 
14B). The delay in structural changes was also evident by quantitative histology of 
growth plate sections, such as shorter growth plate height during tryptophan 
deficiency compared to control, but significantly taller growth plates after recovery of 
the growth inhibiting condition (Fig. 14C). Other studies in rabbits with induced-
hypercortisolism support this concept as well (Baron, Klein et al. 1994; Gafni, Weise 
et al. 2001). 
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Fig. 14. Structural and functional senescent changes in the growth plate were delayed by 
prior tryptophan deficiency. A) Structural markers at different ages, including resting, 
proliferative and hypertrophic zones height; number of resting zone chondrocytes per 200 µm 
of growth plate width; number of proliferative and hypertrophic chondrocytes per column; 
growth plate height; number of hypertrophic columns or column density per 500 µm of growth 
plate width; and terminal hypertrophic chondrocytes height. Each experimental group contains 
4-5 animals. B) Rate of proximal tibia growth per week. C) Photomicrographs of Masson-
Trichrome stained longitudinal sections of proximal tibial growth plate from control and Trp- 
animals at different ages. During the period of growth inhibition (4wk), the overall growth plate 
height in the Trp- animals was smaller than the control animals, despite having significantly 
more resting chondrocytes. At 8-weeks of age, the growth plate height was greater in animals 
that had previously received a Trp- diet (N= 4-5 animals). Bar represents 50 µm. a, Effect of age, 
one-way ANOVA; b, Effect of treatment during the recovery period, two-way ANOVA. 
However, the underlying cellular mechanisms by which growth drives senescence 
and advances the program remain to be elucidated. Postnatal decline in growth rate is 
observed not only in the long bone, but also in many other organs, suggesting a 
common and concordant mechanism to maintain body proportion. In transplantation 
experiments, growth of the transplanted organs generally depends on the age of the 
donor, supporting this hypothesis (Cooke, Yonemura et al. 1986; Pape, Hoppe et al. 
2006).  
Based on our microarray data (paper I), we investigated five genes that increase with 
age and other three genes that significantly decrease with age (Fig. 15). We found that 
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after catch-up growth, previously Trp- rats showed a delay in the age-dependent 
changes in gene expression of Igfbp7, Calca, Prss11 and Pycard compared to 
controls. Because expression of these genes normally rises during senescence, the 
findings indicate that prior Trp deficiency delayed the normal increase. Conversely, 
prior Trp deficiency delayed the normal decline of Igf2 observed in control animals. 
In addition, hypothyroidism but not tryptophan deficiency caused a significant delay 
in the developmental decline of Asb4 expression.  
 
Finally, our findings also provide important insights into the mechanism of catch-up 
growth, which may be partly explained by delayed growth plate senescence. In our 
study, animals previously receiving a Trp- diet have tibial growth rates higher than the 
control animals and appear to have a delayed decline in tibial growth of 
approximately 2 weeks (Fig. 14B). Notably, this delay was similar in magnitude to 
the delay in structural and molecular markers of the growth plates. Taken together 
with previous findings during glucocorticoid excess and hypothyroidism (Gafni, 
Weise et al. 2001; Marino, Hegde et al. 2008), our findings suggest that delayed 
Fig. 15. Prior tryptophan deficiency or prior 
hypothyroidism delayed senescent changes of 
gene expression in the growth plate.  mRNA 
levels were measured by real-time PCR at various 
ages in castrated male rats (left column) and in 
rats that had previously received a tryptophan-
deficient diet (dotted red line, middle column) or 
received PTU to induce hypothy-roidism (dotted 
blue line, right column) along with corresponding 
controls (solid lines).
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growth plate senescence is a general mechanism that contributes to catch-up growth 
after a variety of growth inhibiting conditions. In summary, our findings support the 
hypothesis that delayed senescence is a general consequence of growth inhibition, 
suggesting that growth plate senescence is not a function of time ‘per se’, but rather 
of growth. 
 
4.5 THE ROLE OF miRNAs IN GROWTH PLATE SENESCENCE 
(PAPER V) 
MicroRNAs (miRNAs) are a new class of small non-coding RNA that regulate gene 
expression and has been implicated in the control of several biological mechanisms, 
such as growth proliferation, apoptosis and aging. In order to further characterize 
growth plate senescence and explore the molecular mechanisms that control the 
developmental program of growth plate senescence, we used miRNA microarray and 
real-time PCR analyses to identify miRNA expression in growth plate cartilage and 
also to detect changes in miRNA expression during growth plate senescence.  Here, we 
report original findings of age-regulated miRNAs in mice growth plate during postnatal 
growth, and unique miRNAs preferentially expressed in growth plate compared to 
metaphyseal bone and other tissues. Additional to the microarray profiling, 
bioinformatic analysis of predicted target genes revealed biological pathways likely 
involved in the function of age-regulated miRNAs during postnatal bone growth.  
Furthermore, transfection of selected pre-miRNAs by inhibitory anti-miRNA in 
primary resting zone chondrocytes show that individual miRNAs may contribute to the 
developmentally regulated decline in longitudinal growth, such as miR-195 by 
increasing chondrocytes apoptosis and delaying hypertrophic differentiation. 
 
4.5.1 Developmentally-Regulated miRNAs in Growth Plate Cartilage 
Four miRNAs, miR-195, -497, -125a-3p and -142-3p, were found to be at least 10-fold 
(P<0.01) up-regulated and 14 down-regulated with age in growth plate cartilage (Fig. 
16). It has been shown that miR-195 and miR-497 are down-regulated in several 
cancers, with potential role as tumor-suppressor (Flavin, Smyth et al. 2009). Little is 
known about the function of the other two miRNAs. 
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To explore the biological function and mechanisms of action of age-regulated miRNAs 
in growth plate, first we determined predicted target genes by using TargetScan (Lewis, 
Shih et al. 2003) and then, analyzed their functional role using Ingenuity pathway 
analysis (Ingenuity System Inc, Redwood City, CA) (Guerra 2008). The analysis of 
target genes from both up- (Table 3) and down-regulated miRNAs (Table 4) revealed 
enrichment of genes involved in the control of cell cycle, cell growth and cell death. It 
is important to remark that our data analyze the dynamic process of growth plate 
senescence, in which cell death and cell growth regulation is clearly altered.  In 
addition, canonical pathways most strongly implicated included known pathways 
involved in chondrogenesis, such as TGF-β and Wnt/β-catenin signaling, corroborating 
our findings in the previous studies included in this thesis. In special, Wnt/β-catenin has 
been consistently implicated in postnatal growth plate senescence. In a previous study, 
we have detected that only six members of Wnt family are expressed in mice postnatal 
growth plate, and three of them act through the  Wnt/β-catenin pathway (Andrade, 
Nilsson et al. 2007). Among these Wnts, we found that Wnt-4 is targeted by up-
regulated miRNAs; whereas Wnt-2b is targeted by down-regulated miRNAs. Wnts -5a, 
-5b and -11, which act through the non-canonical/Calcium-pathway, are predicted 
Fig. 16. Expression of miRNAs A) up-
regulated and B) down-regulated in 
6-week-old growth plate compared to 
1-week-old mice growth plates (more 
than 10fold-change). Microarray 
signal values were background 
corrected and normalized. Relative 
expression values (white bars, right y-
axis, n=3) of miR-195 and miR-379 
generated by real-time PCR were 
normalized to sno202, validating 
microarray signal values. 
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targets for down-regulated miRNAs. In the postnatal growth plate, the Wnt/β-catenin 
signaling is necessary for hypertrophic differentiation (Chen, Zhu et al. 2008). 
Inhibition of β-catenin and TCF (ICAT) inhibit β-catenin signaling but not cell 
adhesion, resulting in viable Col2a1-ICAT transgenic mice, with normal size at birth, 
followed by progressive growth retardation during postnatal life. Growth plate of 
Col2a1-ICAT transgenic mice present reduced chondrocyte proliferation and increased 
chondrocyte apoptosis (Chen, Zhu et al. 2008), similar to the phenotype of cartilage-
specific Dicer-knockout mice (Kobayashi, Lu et al. 2008). Interestingly, Wnt/β-catenin 
pathway was also implicated in growth plate senescence in our previous study designed 
to detect changes in global mRNA expression during growth plate senescence (Lui et 
al). Altogether, these findings suggest that miRNAs play an important role in the 
regulation of Wnt signaling during postnatal growth. 
 
miRNAs Up-regulated with age   no. of miRNAs 
P<0.01  21 
P<0.01, Fold Change ≥ 10.0  4 
Target Gene (TargetScan database)   no. of genes 
Predicted targeted genes  803 
Top Molecular and Cellular Functions p-value no. of genes 
Cell Cycle 5,24E-13 - 6,35E-3 116 
Amino Acid Metabolism 1,20E-11 - 6,06E-3 69 
Post-Translational Modification 1,20E-11 - 6,06E-3 120 
Small Molecule Biochemistry 1,20E-11 - 6,35E-3 87 
Cell Death 2,04E-10 - 5,50E-3 210 
Canonical Pathway p-value Ratio 
Axonal Guidance Signaling 3,25E-06 38/403 (9.4%) 
PPARα/RXRα Activation 8,89E-06 22/182 (12.1%) 
Insulin Receptor Signaling 9,54E-06 19/140 (13.6%) 
TGF-β Signaling 1,14E-05 14/83 (16.9%) 
Wnt-β-catenin Signaling 2,63E-05 21/168  (12.5%) 
Ratio = number of genes with P < 0.05 / total number of genes in the pathway 
Table 3.   Target genes regulated by up-regulated miRNAs with age. Bioinformatic analysis of the 
genes targeted by up-regulated miRNAs (more than 10-fold change) in growth plate chondrocytes with 
age (6-week vs 1-week-old mice), by using the Ingenuity Pathway Analysis (IPA) software 8.0 
(Ingenuity Systems Inc, Redwood City, CA). All P values ≤ 0.01 were considered significant. 
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Target Genes regulated by age-down-regulated miRNAs  
miRNAs down-regulated miRNAs with age   no. of miRNAs 
P<0.01  36 
P<0.01, Fold Change ≥ 10.0  14 
Target Gene (TargetScan database)   no. of genes 
Predicted targeted genes  1428 
Top Molecular and Cellular Functions p-value no. of genes 
Gene Expression 4,78E-28 - 1,22E-3 116 
Cell Death 7,92E-14 - 1,22E-3 69 
Cellular Development 1,53E-13 - 1,22E-3 120 
Cellular Growth and Proliferation 4,78E-11 - 9,99E-4 87 
Cellular Movement 9,99E-09 - 1,22E-3 210 
Canonical Pathway p-value Ratio 
TGF-β Signaling 4,01E-09 24/83 (28.9%) 
Wnt-β-catenin Signaling 8,15E-08 35/168 (20.8%) 
Factors Promoting Cardiogenesis in Vertebrates 2,73E-07 22/89 (24.7%) 
Molecular Mechanisms of Cancer 5,81E-07 54/372 (14.5%) 
Axonal Guidance Signaling 4,69E-06 55/403 (13.6%) 
Ratio = number of genes with P < 0.05 / total number of genes in the pathway 
Table 4. Bioinformatic analysis of the genes targeted by down-regulated miRNAs (more than 10-fold 
change) in growth plate chondrocytes with age (6-week vs 1-week-old mice), by using the Ingenuity 
Pathway Analysis (IPA) software 8.0 (Ingenuity Systems Inc, Redwood City, CA). All P values ≤ 0.01 
were considered significant. 
Next, in order to explore the functional role of selected age-regulated miRNAs in 
growth plate chondrogenesis, in vitro gain- and loss-of function experiments in primary 
chondrocytes were performed.  The functional studies in this study were focused on up-
regulated and selected highly expressed miRNAs.  Among the miRNAs that were up-
regulated with age, in vitro gain of function experiments showed that miR-195 
(P<0.001) and miR-497 (P=0.034) increase apoptosis of chondrocytes (Fig. 17B). 
Although miR-195 has been shown to function by promoting cell cycle arrest in other 
tissues (Flavin, Smyth et al. 2009), our findings suggest that miR-195 controls 
chondrogenesis mainly by increasing apoptosis, rather than by decreasing proliferation. 
In addition, gain-of-function of miR-195 in primary cultured chondrocytes also 
decreased mRNA expression of type 10 collagen,   suggesting that miR-195 acts to 
delay hypertrophic differentiation.  Gain-of-function of miR-497 was found to increase 
apoptosis, presumably by down-regulating expression of anti-apoptotic proteins bcl-2 
and bcl-x (Yin, Deng et al.), but did also increase proliferation of primary growth plate 
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chondrocytes. However, by promoting chondrocyte proliferation together with miR-
142-3p (P=0.006) and miR-125a-3p (P=0.012), miR-497 may contribute to the decline 
in chondrocyte proliferation observed in growth plate of cartilage-specific dicer-
knockout mice (Fig. 17). Among the down-regulated miRNAs, the absence of 
phenotype observed in this study may be explained by compensatory mechanisms by 
other miRNAs. 
 
Fig. 17. Gain-of-Function of up-regulated miRNA with age:  A) Gain-of-function of miR-125a-3p 
(P=0.012), miR-142-3p (P=0.006), and miR-497 (P=0.039) increased proliferation of primary 
chondrocytes. Proliferation was assessed by using BrdU proliferation colorimetric kit (Roche). B) Gain-
of-function of miR-195 (P<0.001) and miR-497 (P=0.034) increase apoptosis of chondrocytes compared 
to negative control. Apoptosis was determined by Cell Death ELISA colorimetric kit (Roche). C) Decline in 
Col10a1 mRNA expression after gain-of-function of miR-195. Results are compared to negative control 
(non-specific miR) of treated cells (n=3 biological replicates from three independent experiments. 
Results for proliferation and apoptosis are expressed as percent of negative control, and expressed as 
mRNA relative expression to 18S by real-time PCR for Col10. 
 
4.5.2 MiRNAs preferentially expressed in growth plate cartilage or metaphyseal 
bone 
Our search for potential cartilage-specific miRNAs revealed that miR-455 (37-fold), 
miR-503 (69-fold) and miR-379 (29-fold) were preferentially expressed in 
chondrocytes, in addition to the well known cartilage-specific miR-140 (29-fold) and 
miR-140* (26-fold) compared to metaphyseal bone (Fig. 18A). The magnitude and 
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preferential expression of the cited miRNAs compared to metaphyseal bone and other 
tissues (lung, kidney and heart) suggest that those miRNAs may be necessary for 
specific chondrocyte phenotype and differentiation during postnatal life.  
 
Fig. 18. MiRNAs preferentially expressed in A) growth plate, and B) metaphyseal bone. MiRNA 
expression was more than 10-fold change between tissues throughout life (1- and 6-week-old mice). 
Microarray signal values were background corrected and normalized. Relative expression values (white 
bars, right y-axis, n=3) of miR-140 generated by real-time PCR were normalized to sno202, validating 
microarray signal values. 
Loss-of-function experiments of highly and preferentially expressed miRNAs in growth 
plate showed that miR-140* (P=0.011) and miR-503 (P=0.012) increase chondrocyte 
proliferation (FIG. 19A), thus suggesting that they may be negative regulators of 
longitudinal bone growth. Consistent with our findings, miR-503 has been shown to 
induce cell-cycle arrest (Forrest, Kanamori-Katayama et al.) and inhibit cell growth 
(Jiang, Feng et al. 2009) in other cell types. The importance of miR-140 and miR-140* 
in early chondrogenesis is established, but their functional role remains unknown 
(Nicolas, Pais et al. 2008; Song, Wang et al. 2009; Tardif, Hum et al. 2009). Inhibition 
of miR-455, miR-379, and miR-140 using specific anti-miR inhibitors did not cause 
significant changes in proliferation or apoptosis. Whether this is due to used in vitro 
model or due to a true lack of effect needs to be addressed by further functional studies. 
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Fig. 19. Loss-of-Function of highly and preferentially expressed miRNAs in growth plate: A) Increase of 
chondrocyte proliferation 24h after inhibition of miR-140* (P=0.011) and miR-503 (P=0.012) and other 
preferentially expressed miRNAs in growth plate chondrocytes. Proliferation was assessed by using 
BrdU proliferation colorimetric kit (Roche). B) Measurement of apoptosis after inhibition of miR-140*, 
miR-503, miR-455, miR-379 and miR-140. Apoptosis was determined by Cell Death ELISA colorimetric kit 
(Roche). C) Effect of miRNAs in Col10a1 mRNA expression, by inhibition of miR-140* and miR-503. 
Results are compared to negative control (non-specific miR) of treated cells (n=3 biological replicates 
from three independent experiments. Results for proliferation and apoptosis are expressed as percent 
of negative control, and expressed as mRNA relative expression to 18S by real-time PCR for Col10. 
Importantly, the identification of miRNAs as potential regulators of chondrocyte 
differentiation has clinical implications. The control of several genes and pathways 
important in chondrogenesis makes specific miRNAs attractive therapeutic targets in 
diseases that affect growth development. Our findings contribute to dissect the role of 
miRNAs and their predicted target-genes in endochondral ossification. Further 
functional studies that address the role of individual miRNAs in the regulation of 
growth plate chondrogenesis are needed. 
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5 CONCLUSIONS 
1. We have found novel biological functions, molecular pathways, transcription 
factors and markers implicated in the spatially-associated chondrocyte 
differentiation and temporally-associated senescence of growth plate cartilage, 
which enlighten the search for novel molecular regulatory mechanisms of 
postnatal chondrogenesis. 
2. We have characterized the spatial and temporal expression pattern of Wnt 
family and a network of imprinted genes implicated in embryonic growth 
within postnatal growth plate chondrocytes, suggesting that the identified 
genes may contribute to the chondrocytes differentiation and the fundamental 
biological mechanism that causes the linear growth rate to decline with age.  
3. We found similar delays in functional, structural and molecular markers of 
growth plate senescence markers during different growth inhibiting 
conditions. These findings indicate that growth plate senescence is not simply 
a function of time ‘per se’ but rather of growth, and that delayed senescence 
may be a general consequence of growth inhibition.  
4. We have developed a system for culture and transfection of resting zone 
chondrocytes, which enabled us to study the role of miRNAs in primary 
chondrocytes phenotype, simulating more closely in vivo conditions. 
5. Finally, we identified unique miRNAs that were preferentially expressed 
and/or age-regulated in growth plate chondrocytes and used bioinformatic 
approaches to detect signaling pathways that may be developmentally 
regulated by miRNAs. Functional studies indicate that age-regulated miR-
142-3p, miR-125a-3p, and miR-497 positively regulate proliferation and thus   
act to maintain proliferation during growth plate senescence. Conversely, 
miR-195 and miR-497 may be important in the control of apoptosis that is 
increased during growth plate senescence. Our findings contribute to dissect 
the role of miRNAs and their predicted target genes in the control of 
endochondral ossification.  
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